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This report is one of the outputs of a study commissioned by NHS CFH. The study involved gathering 
data from people in a number of hospitals in England who had been part of the implementation  
of ePrescribing systems. The ideas presented here are based on the actual experiences of NHS staff  
who have worked on ePrescribing implementations.
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Executive Summary
1. Current systems for prescribing and administration of medicines in UK hospitals are based on a model 
established over 40 years ago. Since then medications used have grown in number and complexity, with 
a resulting potential for greater risk to patients. 
2. Electronic prescribing (ePrescribing) systems, where the ordering, administration and supply of 
medicines is supported by electronic systems, offer the opportunity to address such problems, as well as 
to support a robust audit trail and enable potential innovations in the medicines use process. 
3. A growing number of hospitals in the UK have introduced ePrescribing systems, and the earliest 
adopters have had ePrescribing successfully in use for over a decade. This report draws on the lessons 
learned by these pioneers and by those who are currently engaged in moving to ePrescribing. 
4. ePrescribing must be understood in the context of the whole medicines use process, not as  just about 
prescribing or exclusively of relevance to prescribers. Nurses use ePrescribing systems to administer 
medicines, and pharmacists to review orders and manage the supply of medicines. Beyond these central 
stakeholders – doctors, nurses and pharmacists – are many other healthcare professionals who are 
potential users of ePrescribing if and when they need to review a patient’s medication. 
5. ePrescribing systems are widespread in primary care in England, and almost all GP generated 
prescriptions come from a computer system. In secondary care ePrescribing is, as yet, less widespread 
though the number of systems in use is growing.  
6. ePrescribing is seen today in various forms in secondary care in England. Increasingly ePrescribing 
systems are implemented as whole-hospital systems covering all, or almost all, inpatients as well as 
outpatient clinics, and serving the multiple parts of the medicines use process – prescribing, review, 
administration, supply. Some hospitals have implemented systems that only undertake one part of the 
process – for example, support for discharge prescribing. There are other situations, such as in oncology 
or critical care, where specialised systems are used, tailored to the very particular needs of these 
specialties. 
7. The benefits of ePrescribing for all users and all medicines-related tasks starts with the generation of a 
legible and complete medication order. This information can then be shared among multiple healthcare 
professionals, allowing reliable access to medicines information without having to hunt down a single 
paper record.
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8. ePrescribing systems can also provide various degrees of clinical decision support (CDS), to help 
prescribers create orders based on full information about the patient and about the medicines in use. 
For example, a prescriber can be informed about a patient’s allergies, or about potential drug-drug 
interactions. Similarly, during administration a nurse can have access to decision support, for example 
access to laboratory tests or additional administration instructions at the time of administration. 
9. A major motivation for introducing ePrescribing systems is to improve the safety of medicines use 
and reduce the current and unacceptable levels of adverse drug events (ADEs). There are, however, 
other motivations. At the organisation level these may include generating new management data on 
medicines use, establishing and maintaining formularies, and the opportunity to redesign aspects of the 
medicines use process and establish new practices.  
10. The motivation of individual healthcare professionals to use ePrescribing is equally important. Everybody who 
will use ePrescribing needs to understand the overall vision of a more robust medicines use practice and the 
change that accompanies an ePrescribing implementation. But they also need to be motivated by an ePrescribing 
system that is easy to use, and helps them accomplish their own tasks. To help achieve this, clinical users need 
an ePrescribing system that is integrated with other hospital systems such as electronic health records, pathology 
results or patient administration systems, using data drawn from these systems, and feeding data to them.  
11. ePrescribing projects require a strong and committed multi-disciplinary team to lead them. Doctors, 
nurses and pharmacists must work together with other healthcare professionals and managers to 
prepare for ePrescribing implementation. ePrescribing projects  require the active support of senior 
managers and senior clinical leaders, who must be briefed to ensure that they understand the 
challenges of ePrescribing, the changes it will bring and the benefits. 
12. ePrescribing projects take time to be established and to make all the preparations needed before a system 
can be put to use – between one and two years. Throughout this period the ePrescribing project team must 
maintain good two-way communications with senior managers, senior clinicians, information management 
and technology (IM&T) staff and with the front line clinical staff who will work with the ePrescribing system. 
Communicating the overall vision of ePrescribing, building trust and commitment from the wider community, 
and attending to details of procurement, set-up, roll-out, training and support are all important activities for 
the ePrescribing team. This must all be undertaken with an overall focus on safety. 
13. An ePrescribing team needs to communicate across the hospital that ePrescribing will demand changes 
in work practices, and that this implies a need for an active and open approach to learning how the 
system can be used to maximum benefit. The ePrescribing team must be open, taking time to listen to 
concerns of users, their suggestion and enquiries. 
14. ePrescribing teams must not underestimate how long procurement and installation of the equipment 
and software takes. Neither should they underestimate the potential for this technology – networks, 
computers, software systems – to fail. Many sites which have implemented ePrescribing report 
difficulties with, for example, wireless networks, authentication and log-in systems and computers. 
For this reason it is important that the ePrescribing team includes IM&T representatives, and that the 
demands that ePrescribing will make on IT and network infrastructures is fully understood. 
Executive Summary
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15. The sequence and pace of the roll-out of ePrescribing into clinical areas needs careful consideration.  
The specialty where ePrescribing is first piloted will usually be chosen because of the enthusiasm of 
those who work there, but the sequence of subsequent roll-out sites need to be carefully chosen. 
Experience from other sites suggests that, once a system is fully tested in a pilot location, roll-out to the 
rest of the hospital should be as fast as is compatible with safety, so as to minimise the period of time 
where multiple systems are in use. 
16. Once an ePrescribing system has been rolled-out the work of the ePrescribing team will change 
somewhat, but it is not finished. The ePrescribing team that drives an implementation project forward 
needs to be transformed into an ePrescribing support service maintaining the same interdisciplinary 
approach and drawing on multiple skills.  
17. ePrescribing systems need to be managed throughout their lifetime. New staff will need to be trained, 
software will need to be maintained and upgraded, and bugs will appear that need to be corrected. 
More significantly, ePrescribing systems allow many possible innovations in the medicines use process, 
for example increased use of clinical decision support, restructured formularies and prescribing 
permissions, or increased interchange of data with other hospital systems. Real additional benefits of 
ePrescribing come from careful exploitation of these possibilities.  
18. ePrescribing will change how people work – indeed that is in part the aim of introducing such systems. 
Some tasks may become more rigid, demanding a full compliance with a set of procedures, or 
constraining options. Staff can usually understand why this is needed and is desirable, but it is far easier 
for them to accept if the broader benefits of ePrescribing are evident. A successful ePrescribing system, 
however, is not just about more structured tasks. It is also about support for creative use of the data 
generated, help in prioritisation of work, and the ability to reflect on and review practice. 
19. As people start to use an ePrescribing system it will result in various ‘work-arounds’ – ways that people 
discover to get the job done faster or easier. People will, in effect, configure the ePrescribing system 
to meet their particular needs. These ad hoc developments may be desirable and useful, or they may 
be dangerous. In either case work-arounds certainly can tell us about how ePrescribing fits into the 
clinical environment. The ePrescribing support team will need to monitor and assess such developments, 
discussing openly the needs of users, the demands of safety, and what it is possible to achieve. 
20. Implementing ePrescribing systems is a challenge, but one that has been shown to be very achievable. 
ePrescribing systems work, are safe, and once in use most healthcare professionals would never wish 
to return to a paper-based system. They offer many advantages both at the level of medicines related 
tasks, but also in supporting management and practice development aims, and in particular innovation 
in medicines use processes.  
21. Fundamentally, ePrescribing needs to be seen as part of the overall strategic direction for any hospital, 
a central part of an evolving set of information systems that serve multiple professional groups, patients 
and their carers, and that extend beyond the secondary care setting.
Executive Summary
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CHAPTER 1
Introduction 
Medicines are at the very heart of modern medicine. 
However, the systems for prescribing and administering them have remained largely 
unchanged for the last forty or fifty years. Meanwhile the medications used have  
increased in number and complexity, resulting in potentially greater risks for the patient  
of medication error.
For UK hospital inpatients, the systems used for prescribing medications 
and recording their administration are based on a model established in 
the 1960s. Doctors write medication orders directly onto a paper drug 
chart or medication Kardex, and the same document is used by nurses 
to find out the doses due and record administration to the patient. This 
document is also used by pharmacists to screen and supply medication, 
as well as by other healthcare professionals when they need to view a 
patient’s current medication. 
But there are known problems with this system. UK studies show that:
•	 prescribing errors occur in 1.5-9.2% of medication orders written for  
hospital inpatients 1-5
•	 dispensing errors are identified in 0.02% of dispensed items 6-7
•	 medication administration errors occur in 3.0-8.0% of non-intravenous  
doses 2, 8-15 and about 50% of all intravenous doses.16-18 (These figures 
exclude errors involving wrong time of administration). 
 
Given these figures, and the general understanding that medication errors are one of the 
major preventable sources of harm in healthcare, it is not surprising that computerisation of 
the prescribing and administration processes is advocated as a way to reduce these errors. 
This, together with growing needs for formulary control and audit, has led to widespread 
recommendations for the introduction of electronic prescribing (ePrescribing) systems in the 
UK.19-21  Similar pressures are seen in the USA  where ePrescribing systems have been in use in 
some hospitals for some time, driven by the additional requirement for individual patient billing 
and the greater efficiency gains associated with computerising the more labour-intensive unit 
dose drug distribution system used in most US hospitals. Based on studies undertaken in the 
USA the Leapfrog Group http://www.leapfroggroup.org argues that  ePrescribing can reduce 
errors , Adverse Drug Events and costs, and encourages hospitals to implement such systems.
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To date, only a few UK hospitals have introduced comprehensive ePrescribing systems, 
although there are some notable exceptions. Queens Hospital, Burton on Trent, has had 
computerised prescribing as part of a hospital-wide integrated information systems for 
over 10 years and in 2006 The Royal Hampshire Hospital in Winchester became the first 
hospital in Europe to replace one ePrescribing system that had been in use for many 
years with another. The limited uptake of ePrescribing by secondary care in the UK is 
in direct contrast to the situation in primary care where ePrescribing is now the norm 
and the electronic transmission of prescriptions from general practitioners to high street 
pharmacies is being implemented through the Electronic Prescription Service (EPS) (see
 http://www.connectingforhealth.nhs.uk/systemsandservices/eps). 
The relatively modest scale of ePrescribing in the UK acute care 
setting might be explained by a number of factors. These include a 
perception that ePrescribing is technically difficult and challenging, 
that available systems are not sufficiently well developed to deliver 
benefit, that other systems need to be in place before ePrescribing 
is rolled out, or that the culture change required for adoption into 
clinical practice is too hard to achieve. 
Certainly each of these concerns has some validity, but recent experience  
in UK hospitals shows that ePrescribing projects can surmount them all.  
Indeed, attitudes are changing and at the time of writing (January 2009)  
the planning and implementation of ePrescribing in UK acute care 
is underway at a growing number of sites. Building on this pool of 
experience, the work reported here challenges such negative perceptions 
of ePrescribing. Drawing on the understanding and experience of people 
who have participated in ePrescribing implementations in NHS hospitals 
in England, this report conveys a different message; ePrescribing is very 
achievable, and the benefits are well worth the effort. But ePrescribing 
does require careful planning and a multidisciplinary team effort to 
achieve a successful implementation. 
A note on terminology 
NHS Connecting for Health’s formal definition of ePrescribing is as follows: 
The utilisation of electronic systems to facilitate and enhance the communication of 
a prescription or medicine order, aiding the choice, administration and supply of a 
medicine through knowledge and decision support and providing a robust audit trail for 
the entire medicines use process (NHS Connecting for Health, 2007). 
Elsewhere in the world ePrescribing systems are referred to by various other names.  
In the USA, and thus much of the research literature, the most commonly used term 
is the abbreviation CPOE, although what it stands for has shifted from ‘Computerised 
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Physician Order Entry’, to ‘Computerised Provider Order Entry’, in line with the expansion of 
prescribing authority to other groups of staff. 
CPOE, as discussed in the US literature, often encompasses medical orders other than medicines 
such as those for laboratory tests, physiotherapy and imaging. In the UK, the term CPOE is not 
generally used and traditional UK practice has been to separate orders for medication from 
other medical orders. For this reason, in the UK, it is more common to speak about ePrescribing. 
Today’s ePrescribing systems include electronic medication administration records  
(eMAR) where medication administration can be documented and screened electronically. Some 
hospital sites in the UK use the alternative acronym of EPMA  
for their system, standing for Electronic Prescribing and Medicines Administration 
In line with current UK (NHS CFH) practice, we use the term ’ePrescribing’ in this report, while 
recognising that  most inpatient ePrescribing systems provide supply, administration and 
recording functions as well as prescribing, and that nurses are probably the professional group 
who spend most time working with ePrescribing. 
Aim of this Report
The work reported here was commissioned by NHS CFH with the aim of identifying the lessons to 
be learnt from various UK hospital trusts who have already implemented ePrescribing, and using 
these experiences to brief those who are yet to do so. This report is largely based on interviews 
and questionnaires conducted with over 50 staff in 13 NHS trusts who have been involved with 
the implementations of 20 different systems; we also draw on the national and international 
literature. 
The aim of this report is to communicate the lessons that have been learnt to those who will 
be involved in future hospital-wide implementations. The study’s specific objectives are given in 
Appendix 1.
The structure of the rest of this report is as follows: 
•	 Chapter 2 gives an introduction to ePrescribing systems and their functions, highlighting the 
key people who will use them and summarising the benefits.
•	 Chapter 3 discusses the various motivations that may make a hospital or trust wish  
to move to ePrescribing. 
•	 Chapter 4 presents the key lessons learned that have emerged from the study undertaken 
for this report - lessons drawn from people who have actually gone through ePrescribing 
implementations.
•	 Chapter 5 is concerned with the safety of ePrescribing, a key concern of  
all implementers.
•	 Chapter 6 considers the agenda of issues that an ePrescribing planning team will need to 
consider, and the make-up of the team itself.
Challenges and lessons learned PAGE 11
CHAPTER 1Introduction
•	 Chapter 7 is concerned with managing an ePrescribing system in use - remembering 
that this is not a “fit and forget” bit of technology, but a socio-technical system that 
needs to be sustained and developed throughout its period of use.
•	 Chapter 8 discusses the various technical elements that are found within ePrescribing 
systems, including hardware, databases and networks.
•	 Chapter 9 concludes the report with a discussion of ePrescribing within the emerging 
landscape of eHealth.
A list of abbreviations is given in Appendix 3.
Each chapter is written with the aim of being accessible if read alone, although we 
recognise that this does lead to some repetition. Thus the report and the accompanying 
materials are intended to form the basis of a toolkit that can be used in a variety of 
settings to support successful planning for the implementation of ePrescribing.   We 
have aimed to write each chapter using relatively straightforward language so as to be 
accessible to a wide range of hospital staff. 
This report is accompanied by six user briefing notes (‘briefs’), which are intended 
to provide quick and insightful briefing for the key stakeholders: doctors, nurses, 
pharmacists, information technology staff, project team members and chief executives 
and senior managers. 
Finally, associated with this report are summary PowerPoint presentations  
suitable for supporting local implementation activities.  
For copies of all materials see: www.connectingforhealth.nhs.uk/eprescribing
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Challenges and lessons learned
What is ePrescribing? 
The NHS Connecting for Health (NHS CFH) definition of ePrescribing is as follows: 
 
The utilisation of electronic systems to facilitate and enhance the communication of 
a prescription or medicine order, aiding the choice, administration and supply of a 
medicine through knowledge and decision support and providing a robust audit trail for 
the entire medicines use process. 
This definition emphasises that ePrescribing is about communication, certainly more than 
just prescribing, and encompasses supply and administration as well as other functions 
such as audit. 
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ePrescribing systems: their 
functions and potential benefits 
Key messages 
•	 ePrescribing is about much more than prescribing, and involves various healthcare professionals 
who all have a role in ensuring medicines are used safely as part of patient care.
•	 ePrescribing projects therefore have many important stakeholders; a team approach  and senior 
management buy-in are both essential.
•	 ePrescribing systems come in a variety of shapes and sizes, as is appropriate to various settings, 
but most are based on commercially produced packaged software .
•	 Increasingly we see whole hospital systems being implemented, but many ePrescribing systems 
are also found in specialist areas such as oncology or critical care. 
•	 The benefits of ePrescribing originate in the generation of legible and complete medication 
orders, and in the sharing of this information among multiple healthcare professionals 
undertaking different tasks.
•	 Based on such data various degrees of decision support can help in both prescribing  
and administration. 
•	 Additional benefits are seen with ePrescribing systems that integrate with other hospital  
systems, for example with pathology. 
•	 Successful implementations demonstrate the many real benefits that ePrescribing  
can bring. 
•	 Careful planning and teamwork are the basis of successful implementations.
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ePrescribing involves many types of healthcare professional, and 
certainly not just prescribers (be they doctors, pharmacists or nurses). 
Nurses and pharmacists, alongside doctors, are the ‘obvious’ key 
stakeholders for functions such as administration and medicines 
review, but physiotherapists, dieticians and other healthcare 
professionals also use inpatient ePrescribing systems when they need 
to know about a patient’s medicines.
Who is involved with implementing ePrescribing?
Because all these healthcare professionals have an interest in using ePrescribing, the implementation 
of ePrescribing systems has to involve a number of clinical stakeholders as well as the Information 
Management and Technology (IM&T) professionals who are responsible for the technical infrastructures that 
support ePrescribing.  But before anything it is essential that senior managers and senior clinicians are well 
informed about and committed to ePrescribing. Without such senior support ePrescribing projects will be 
far less able to weather the inevitable setbacks.  
 
Hospitals undertaking ePrescribing implementations should also aim for an ongoing relationship with 
the supplier of the software used so as to be able to draw on their experience and knowledge, to resolve 
problems promptly, and to participate in the future developments of the software’s functionality. 
The consequence of ePrescribing touching so many peoples’ interests is that implementing ePrescribing 
must be understood as involving more than just a change from paper to electronic prescriptions; it inevitably 
involves considerable changes to working practices and culture for all who work with it. For example, for a 
nurse on a ward it can change the structure of the drug round, for a doctor it can change the prescribing 
process by using order sets – groups of medicines that can be ordered as a whole - for common conditions 
and procedures, while for a ward pharmacist their visit may be preceded by a review of patients from a 
remote terminal, allowing prioritization of those who most need attention.
ePrescribing works best when it is approached as a joint or collective 
project that brings people from different professions together. We 
cannot stress this enough; one primary finding from our respondents 
is that in order to make ePrescribing ‘work’ and deliver the potential 
benefits, a multi-professional approach is essential, involving 
all relevant stakeholders.  A common commitment to making 
ePrescribing work and obtaining benefits from it needs to be made 
by all stakeholders well before implementation starts, and needs to 
continue long after the initial implementation stage is finished.
 
Where in the hospital are ePrescribing systems found? 
ePrescribing systems can be, and increasingly are, implemented hospital-wide, serving almost all aspects of 
medicines use. There are still, however, some areas that prove more complex to integrate into a hospital-
wide system, for example Accident and Emergency (A&E) departments, or areas which will use their own 
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healthcare professionals 
also use inpatient 
ePrescribing systems
To make ePrescribing 
‘work’ a multi-
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Challenges and lessons learned PAGE 15
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specialist systems, for example critical care units. Similarly, there 
may be situations when a comprehensive hospital-wide ePrescribing 
system cannot be achieved, and certainly not overnight, and some 
specialities may be left out or delayed in receiving ePrescribing. 
The following are examples of where and how ePrescribing 
systems are currently used in NHS hospitals in England:
•	 Inpatient wards – often with one or two specialist clinical areas 
(such as critical care or paediatrics) that are exceptions or where 
implementation is delayed.
•	 Outpatient clinics – sometimes this area is implemented first, sometimes last.
•	 Discharge prescribing – many examples of standalone systems used to produce discharge 
summaries incorporating discharge prescriptions.
•	 Critical care areas – here, requirements are often served by specialist ePrescribing software 
with a particular focus on recording administration of continuous intravenous infusions.
•	 Chemotherapy clinics and day care centres – chemotherapy prescribing is complex, 
and requires careful and controlled prescribing and administration. Again, specialist 
ePrescribing systems are often used, sometimes supported by specific funding.
•	 Operating theatres – ePrescribing may at times be used to prescribe in the operating 
theatre, but even if not used for prescribing access to information about the current 
medication will usually be required.
•	 Dialysis centres and other day-care units.
We should also add that most ePrescribing systems are implemented in the pharmacy too, 
facilitating supply and monitoring, as well as allowing discharge prescriptions to be received 
directly. Indeed, many ePrescribing systems are directly interfaced with the pharmacy software 
and share common databases, for example formularies and lists of drugs and doses available. 
This also avoids pharmacy staff having to re-enter details of the medication required in order 
to make a supply.
What about the ePrescribing software? 
Almost all ePrescribing implementations in the UK, be they hospital-wide or restricted to some 
specialty, are based on commercially available software purchased from specialist suppliers. 
Such software provides the essential functionality of identifying patients, entering structured 
and complete prescriptions, screening them and documenting administration.  
Additional functionality that may be available includes various degrees of help for prescribers 
including access to information sources (e.g. online BNF or formulary) and cross checking with 
available patient data (e.g. for allergies). There will usually also be a database that can support the 
identification of drug-drug interactions, and perhaps of drugs prescribed in doses outside of a pre-
defined range. These aspects are often loosely described as Clinical Decision Support (CDS).
ePrescribing systems 
can be specific to one 
clinical specialty, one 
stage of the prescribing 
process or (almost) 
hospital-wide
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Figure 1: an example of an ePrescribing prescribing screen
Healthcare professionals interact with ePrescribing software through terminals of various 
types and via different screens adapted to specific tasks.
Figure 1 shows a representation of a prescribing screen. The medicines that have already 
been prescribed – current medications - are shown on the left, with dose and frequency. 
A new order for doxycycline is being selected from a drop down list generated by typing 
the first three letters ‘dox’. This selection has then triggered an allergy alert for this 
patient.   The alert invites the prescriber to cancel their selection as the default action, or 
they can continue to prescribe this medicine. 
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Figure 2: an example of an ePrescribing administration screen
Figure 2 shows a representation of an administration screen, as might be used by a 
nurse. The medicines to be administered at this time are shown in the context of the 
previous two days administrations. Due, overdue and as required doses are indicated. 
The nurse can then tick and sign off the doses administered on this round. In both 
figures 1 and 2 the screen also contains information to allow the identification of the 
patient, name, ward, bed, date of birth and NHS Number.
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What functions does ePrescribing support,  
and who is involved? 
Figure 3 represents a very simple generic inpatient ePrescribing system, highlighting 
the primary functions and the primary actors (people or systems) who interact with 
the system. Thus a basic inpatient ePrescribing system will support one or more of 
the following functions: prescribing by doctors and other authorised prescribers, 
administration by nurses, supply of drugs by pharmacy staff, and screening by 
pharmacists. Each of these functions are represented by the bubbles in the figure, where 
each simple bubble (prescribe, supply etc.) represents a more complex set of activities 
supported by appropriate interactive screens. 
Pharmacist
Doctor/
prescriber
Nurse
ePrescribing
System
Prescribe
Review
SupplyAdminister
Figure 3: a very simple model of the functions of ePrescribing and the primary actors
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The very simple model in figure 3 of course needs some elaboration as the four basic 
functions identified, in almost all cases, require the attention of more than one actor. 
Thus in figure 4 we start to see that ePrescribing is much more than separate and 
discrete functions that cater to distinct professional groups, but rather is a mediating 
system that helps to coordinate the work of the various actors and thereby help to 
ensure safe and effective care for the patient. 
In figure 4, for example, we acknowledge that both nurses and pharmacists are 
involved in supply, and that pharmacists may be involved in prescribing for example if a 
pharmacist attends ward rounds and does the actual input of medicines orders on the 
medical team’s behalf. With increasing numbers of nurses and pharmacists qualifying as 
independent prescribers, many will also be prescribing in their own right.
Pharmacist
Doctor/
prescriber
Nurse
Prescribe
Review
SupplyAdminister
ePrescribing
System
Figure 4: model adapted to show secondary users of functionalities;
Solid lines - principal actors involved; dotted lines - secondary actor
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Both figures 3 and 4 give a useful overview of ePrescribing systems, but they are still an 
over-simplification. Figure 5 shows a further set of functions that an ePrescribing system 
may support, and more of the actors who participate. 
The functions identified include patient admission and discharge, as well as the 
involvement of other healthcare professionals who need to view (read) medication 
records. These may include such people as dieticians, microbiologists, the pain team, 
physiotherapists, occupational therapists and others.
  
ePrescribing
System
Pharmacist
HCP (Physio)
Carer
Patient
Doctor/
prescriber
Manager
Nurse
EMR Drugs
database
Hospital
PAS
Pharmacy
stock control
Prescribe Discharge
ViewAudit
Review
Admit
Administer Supply
Figure 5: more complex ePrescribing system with more extensive functions and interactions
Solid lines - principal actors; dotted lines - secondary actors 
HCP: Healthcare professional 
PAS: Patient administration system 
EMR: Electronic medical record 
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Note that actors who interact with ePrescribing can be human (e.g. managers,  
doctors, nurses), but also technical, (e.g. the PAS, drugs database or EMR shown here). 
We also include here the patient and carers as relevant actors, for example in the  
process of discharge. 
Figure 5 may appear complex, implying the resulting complexity of ePrescribing 
implementation, but it is exactly because ePrescribing systems can integrate these  
distinct activities, and these various actors (human and technical), that they are so 
valuable and able to contribute to improved patient care. Similar diagrams could also be 
drawn for outpatient and discharge ePrescribing systems to indicate the scope and range 
of these systems. For a more detailed account of ePrescribing functionality see  
the ePrescribing functional specification for NHS trusts prepared by NHS Connecting  
for Health (2007).1
What are the different types of ePrescribing software  
in use in the UK? 
ePrescribing may not yet be commonplace in the UK, but there is a surprisingly wide 
range of systems in use across the NHS. Some of the existing systems are specific to 
one clinical specialty (e.g. critical care or oncology), others are specific to one stage of 
the prescribing process (e.g. electronic discharge prescription systems), while others are 
hospital-wide (or almost hospital-wide).
Systems in use today include those that have been developed “in house” by committed 
enthusiasts such as the system at University Hospitals Birmingham, those that are based 
on software packages that have been developed out of pharmacy systems (e.g. JAC and 
Ascribe), and those that form part of a wider implementation of hospital information 
systems (e.g. Meditech). Some are linked to controlled access cupboards on wards and 
bar code patient identity checks (e.g. ServeRx). 
ePrescribing is a core module of the NHS NPfIT packages iSoft Lorenzo and Cerner 
Millennium, which are a central part of the NHS Care Records Service. These systems 
plan to deliver ePrescribing as an integral part of a whole patient e-health record. 
The functionality of the systems in use today may include some of the following. Most 
systems in use do not achieve all of these, certainly not in their initial phases of use: 
 
•	 Inpatient prescribing with varying degrees of clinical decision support and support for 
different areas of clinical specialty
•	 Outpatient prescribing with varying degrees of clinical decision support 
•	 Linkages to other systems including chemical pathology
•	 Pharmacist screening, usually available remotely to the ward or clinic
•	 Viewing of current medicines by other healthcare professionals
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•	 Electronic administration and recording with varying degrees of support for drug 
administration rounds
•	 Electronic patient identification
•	 Ward stock control and supply 
•	 Discharge prescribing 
•	 Reporting for clinical staff (eg monthly report, ad hoc reports, audit data) 
 
What are the potential benefits? 
ePrescribing can deliver benefits for those who prescribe, administer, screen and dispense 
medication, as well as those who need to see medication records on a “read only” basis. 
Each of these will be considered in turn: 
Prescribing 
When prescribing, ePrescribing can help in a number of ways and various situations: 
•	 Allowing prescribing from remote terminals/sites as well as at the bedside 
•	 Providing prescribers with access to decision support
•	 Helping to support the use of a trust formulary
•	 Allowing the use of order sets or combinations of drugs in pre-specified packages 
•	 Allowing access to electronic patient records (as well as medication records) 
•	 Removing the need to rewrite medication charts, and the associated potential for 
transcription errors 
•	 Supporting direct communication of prescribing information to pharmacy and  
other departments
•	 Allowing the easy and direct production of discharge prescriptions
CDS ranges from the most basic (access to a drug dictionary) to the very complex, for 
example checking medication orders against patients’ laboratory results and documented 
co-morbidities.
Examples of decision support in use in current implementations of ePrescribing include 
the following:
•	 Drug dictionary 
•	 Formulary information 
•	 Enforced requirement for complete orders with no information omitted
•	 Default doses
•	 Preventing prescribing of doses that are impossible to administer using the dosage 
forms available
•	 BNF lookup 
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•	 Drug-allergy checking 
•	 Drug-drug interactions checking
•	 Checking doses against renal function 
•	 Checking doses against patient’s age 
•	 Checking doses and drug choice in relation to patients’ laboratory results 
•	 Checking drug choice against documented co-morbidities
As noted above, most systems do not support all of these aspects of 
clinical decision support, and sites with experience of ePrescribing 
report the need for careful and incremental inclusion of CDS, 
undertaken in consultation with clinical staff. Done well CDS is the 
key to many benefits of ePrescribing, done poorly it can prejudice 
users against a system.
Administration 
ePrescribing is just as important and useful when it provides support 
for the administration of drugs. For example it can help by: 
•	 Supporting the supply of medicines to the ward in a timely fashion 
•	 Facilitating patient identification at the bedside (e.g. using barcodes) 
•	 Removing the problem of missing or illegible drug charts 
•	 Prompting when doses are due 
•	 Allowing easy review of previous medication history 
•	 Extending the amount of information available during administration 
•	 Allowing access to electronic patient records (as well as medication records) 
Review, screening and dispensing of medication 
ePrescribing can have significant positive consequences for pharmacists as they check 
(“screen”) medication orders, correct errors and follow up queries. There is the potential 
to change the ways in which pharmacists work, for example doing more screening from 
the pharmacy department before visiting patients on a ward (although this has both 
advantages and disadvantages). Benefits are as follows:
•	 Allowing easy review of previous medication history 
•	 Access to electronic patient records (as well as medication records) and sometimes 
pathology results  
•	 Removing the problem of missing or illegible drug charts 
•	 Screening is possible at remote locations (although this also has its pitfalls) 
•	 No requirement to check transcription of new paper drug charts  
Done well, clinical 
decision support is 
key to many benefits 
of ePrescribing; done 
poorly, it can prejudice 
users against the system
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•	 Many basic prescribing errors (missing information, transcription errors from one 
chart to another, prescribing doses that are not possible with the dosage forms 
available etc.) are likely to be prevented and will not need to be corrected 
•	 Clear audit trail for changes to medication 
•	 Identification of each individual prescriber to allow follow up of queries 
•	 Supporting the transfer of information from secondary to primary care and vice versa
Viewing medication records 
The traditional drug chart serves often as a quick review of a patient’s condition and 
the medicines they are on. Many healthcare professionals need to be able to access this 
information as part of their work, and will benefit if it is directly available. ePrescribing can 
help by:
•	 Allowing easy review of current and previous medication history 
•	 Access to electronic patient records (as well as medication records) 
•	 Removing the problem of missing drug charts or not being able to access those that 
are in use by other healthcare professionals
•	 Viewing is possible at remote locations (although this also has its pitfalls) 
Conclusions 
Overall, the benefits of ePrescribing can be summarised as improved safety of medicines 
use resulting from three main contributory factors:
•	 More legible, complete and available medicines orders 
•	 Decision making backed up by suitable information resources
•	 Richer and more timely interactions among the care team
However, while the benefits outlined here have been shown in the research literature 
and are supported by the accounts of the NHS staff who have contributed to this study, 
there is also evidence that poor implementation of ePrescribing can be hazardous and 
cause patient harm.2  Thus in the following chapters of this report we focus on the 
details that need to be attended to in order to allow an ePrescribing implementation to 
deliver its full potential.
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Motivations for  
ePrescribing adoption
Introduction
Much attention in the last decade has been focused on the unacceptable frequency of 
occurrence and consequence of adverse drug events (ADE); events that occur during or 
following medication use due to adverse drug reactions, poisoning or errors in the medicines 
use process. Research has shown the potential for ePrescribing to make a real difference to 
patient care by preventing errors and reducing ADEs. For this reason ePrescribing has been 
promoted through national polices and incentives as one of the main ways of optimising 
patient care and minimising harm. 
Though patient safety is usually a main driver for ePrescribing, 
motivation for implementation and predictors of successful 
adoption of ePrescribing are more diverse. The reasons for adopting 
ePrescribing may be very different at the organisational level, 
compared to that at the user level.1  For example, at the trust 
level ePrescribing should be seen as part of a broader strategy of 
computerisation, information management and the exploitation 
of new technology. Within this perspective ePrescribing may be just one part of the way 
forward. For some organisations, with ePrescribing comes the prestige of being at the cutting 
edge of technology, a pioneer. For others, it is a way of improving processes and practices 
which will in the long run contribute to improved patient care in general (for example speedy 
and efficient discharge), as well as safety. 
The reasons for 
adopting ePrescribing 
may be very different  
at organisational and 
user levels
Key messages  
•	 A major motivation for ePrescribing is greater safety of drug use and the current unacceptable 
levels of adverse drug events.
•	 There are other significant motivations for ePrescribing at the organisational level including 
availability of new management data, efficiency gains and the reinforcement of good practice.
•	 Individuals also need to be motivated to use ePrescribing. Ease of use and direct task 
accomplishment are important motivators, but so too is understanding the overall vision that 
ePrescribing serves.
•	 Linking ePrescribing to other existing or future information systems is important to users.
•	 So, too, is a good understanding of the incremental delivery of benefits over time.
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Research undertaken in the USA has shown that CPOE systems that include ePrescribing can be 
remarkably effective.  For example, in one study they reduced error rates by 55%, and serious 
medication errors by 88%.2 – 3 These improvements are largely attributed to the use of structured 
orders and checks as well as more extensive decision support by prescribers.  Other studies have 
shown length of stay reducing by nearly a day following implementation of CPOE.4 It has been 
asserted that introducing CPOE into U.S. hospitals could prevent between 570,000 and 907,000 
serious medication errors each year.5
However these studies, and their findings, must be carefully assessed. They come from a 
few early adopter sites in the USA, which has a very different health system, usually using an 
ePrescribing system designed specifically for them. It is not clear if, or how rapidly, or to what 
degree, these benefits might be seen in the UK.  Given the distinct and different context of 
UK hospitals and prescribing practices, and our use of ePrescribing based on implementing 
commercial packaged software, we should treat this evidence cautiously. It can certainly point 
to areas in which benefits might hope to be seen, and it can help implementers to collect 
appropriate base-line data so that they can monitor outcomes. What it cannot do is set sensible 
benchmarks for expected benefits soon after implementing a system.
Motivations for ePrescriptions can include:
•	 Reducing medication errors
•	 Improving documentation and communication about medication
•	 Providing information at the point of medicines use 
•	 Enforcing policies and promoting good practice 
In these ways ePrescribing can have significant influence on the overall levels of patient care. 
But the motivations for ePrescribing should go further and wider. For example, a finance officer 
may relish the possibility of accurately capturing the costs of medication for individual patients; 
the drugs and therapeutics committee (D&TC) may see formulary enhancement; the Director of 
Infection Control may see new ways of monitoring appropriate antibiotic use; while a chief nurse 
may see it as a way to audit nurse administration. Senior managers, too, gain direct benefits 
from ePrescribing; one chief executive was reported to us as saying that ePrescribing was the first 
real-time data system found in the trust.
Individual users may share their organisation’s motivations and vision, particularly if they are 
introduced to that vision and included within it. However, willingness to use ePrescribing is more 
likely to be influenced by how ePrescribing affects the individual user and their practices and 
workflow on a day-to-day basis. Performance of an ePrescribing system in terms of the time 
taken, ease of use, its tailorability (how easy it is to adapt the system to the hospital, ward or 
profession’s needs) and compatibility with other systems will all influence adoption.
Clinical staff who will use ePrescribing will want to know the transitional and long terms effects 
of ePrescribing on their individual practice. For this reason establishing evidence that the system 
Challenges and lessons learned PAGE 27
CHAPTER 3Motivations for ePrescribing adoption
is having a positive effect on work practices and safety, and providing 
feedback on the performance of the system and outcomes in terms 
of patient care, are very important as a way of gaining support and to 
keep momentum going. This includes the need to capture information 
on less desirable effects of ePrescribing, such as new types of errors or 
unexpected effects on work practices, and to consider changes to the system that can mitigate 
these. For this reason, among others, an ongoing and appropriately resourced support service is 
essential to a successful ePrescribing system, both through the implementation period and beyond. 
Moving to using ePrescribing involves a major change for the organisation.6  The magnitude of this 
change, and the risks associated with it, should not be underestimated. Leadership and support 
from the top level are imperative to manage this change. It is important that healthcare professionals 
understand the exact scope and role of ePrescribing at their organisation, and the timescale within 
which it is being introduced. Organisations planning to implement ePrescribing should consider 
context-specific answers to the questions below when communicating their motivations:
Is it quicker? 
On the face of it, ePrescribing is rarely faster than using paper systems for specific tasks of 
prescribing or administration, certainly not in the early phases. However, there may be savings 
in the overall time spent on activities. As one doctor noted, it took longer to prescribe new 
medicines, but this was offset by not having to rewrite prescription charts every two weeks. 
How will ePrescribing fit in with the ‘normal’ way of doing things? 
Some see ePrescribing as an opportunity to improve the way in which things are done. One 
ward sister found it very useful to remove drug administration times of 8 o’clock as this was the 
nursing handover time and therefore medicines would not be given at that time anyway. 
Others may initially consider ePrescribing more restrictive compared to existing practice, but 
recognise that it promotes good practice. For example, mandatory allergy status and weight 
entry in one hospital meant that prescribers could not continue to prescribe unless this 
information was entered. Such a forcing function needs to be used with care, and depends on 
the overall understanding of the user to endure the pressure to achieve wider benefits.
Can I have my own menus, screens or reports? 
The ability to tailor ePrescribing to local or even individual needs 
might provide a sense of ownership of the system which is more 
likely to encourage use. However, the possibility and extent to which 
local tailoring of ePrescribing is undertaken will depend on individual 
systems and how they are configured for the particular hospital.
There certainly should be opportunities, for example, to develop targeted reports from an 
ePrescribing system according to the needs of different staff, but reconfiguring standard screens 
for prescribing or administration, for example, would be a serious safety concern.
An appropriately 
resourced support 
service is essential
The ability to tailor 
ePrescribing to local 
and individual needs 
can provide a sense of 
ownership of the system
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Will it interact with the other IT systems that I use? 
Many users consider ePrescribing more useful if it interacts and integrates outputs from 
other IT systems, such as pathology results. If such systems exist, then an ePrescribing project 
should probably link to them from the initial implementation. Where this has not happened, 
for example where discharge systems are stand alone and separate from the ward-based 
ePrescribing, this has led to staff frustration at what seems to them a senseless lack of  
joined-upness. 
If multiple systems do interact, then they need to do so in as seamless a way as possible, and 
one that is demonstrably safe. For example, there should be a single login for the user, not 
multiple logins, and it should be impossible to mix data from one patient with that of another 
(e.g. have an x-ray for one Mr Smith on screen, with the medicines for another).
Understanding of scope and role of ePrescribing
A clearly communicated vision sets the expectations of users and is central to successful 
implementations. 
A key message to establish at the outset is that ePrescribing covers the whole drug use 
process, and does not only serve prescribers or prescribing. In practice, we must understand 
that nurses are the professional group who probably spend most time using an ePrescribing 
system, followed by pharmacists and doctors. The biggest change in work practice, however, 
may be for doctors.  Different users of ePrescribing will have different aspirations for the 
system, and come with different prior understandings of what it can do. 
Without a well articulated and shared understanding of the role and scope of ePrescribing 
implementation can be far more difficult. Lack of inclusion or common understanding can 
influence other healthcare professionals to be less involved or committed to ePrescribing at 
the outset, if they believe that it has little to do with them. More subtly, this assumption may 
skew the ways in which engagement is organised and evaluated. 
Another key message that needs to be communicated is how long 
ePrescribing implementations take, and the various achievements that 
can be expected along the way. Some benefits will be immediately 
available, notably legible and available medicines information, 
while some may be delayed. For example, a key benefit of having 
an ePrescribing system may be allowing automatic population of 
the electronic discharge summary, but this benefit may rely upon 
two separate systems (ePrescribing and discharge) both working and being interfaced. This 
benefit may be significant and could, for example, compensate doctors for the time they 
spend typing in orders if they gain a benefit when they come to do the discharge summary. 
Some benefits will  
be immediately 
available, while some 
may be delayed
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Where and how does ePrescribing fit in the medicines 
management process? 
Depending on the functionality available within an ePrescribing system, its implementation 
may affect all parts of the medicines management process and not just prescribing. There 
may be significant improved efficiency in some processes, whilst other elements may 
change completely. For example, order sets can make it easier to prescribe combinations of 
medicines; use of barcodes during administration can markedly change the steps involved 
in patient identification at the bedside; electronic transmission of discharge prescriptions to 
pharmacy may potentially speed up the supply of discharge medication, though it may be 
more complex if a ward check of patient’s own drugs (PODs) is needed. 
Of course, speeding up the transmission of discharge (TTO) orders to Pharmacy will save 
little time if dispensing is not equally timely, and certainly ePrescribing should not be 
seen as a means to undertake staff cutbacks. Such savings has been a common theme 
in some discussions of ePrescribing, and sometimes have been enacted with the result 
that ePrescribing leads to a weaker pharmacy service. We should, however add that 
ePrescribing does allow healthcare professionals to improve their effectiveness in many 
ways, such as pharmacists no longer seeking charts and spending time correcting minor 
prescription errors and so being able to focus on ensuring that pharmacy services better 
reflect the needs of the patient. 
Where does ePrescribing fit in overall computerisation efforts? 
Seeing ePrescribing as a part of a larger programme of beneficial change may influence 
implementation outcomes. Short term frustration with a system may be seen as 
acceptable if longer term benefits are understood. 
A part of this is explaining how ePrescribing interfaces to other existing or projected 
systems within the trust (e.g. patient administration system, laboratory results) as well 
as nationally (e.g. electronic patient records and the NHS Care Record Service). Given 
the high profile of the National Programme for IT and the very substantial effort that is 
underway to implement a range of national systems, it is important that ePrescribing is 
seen as distinct, separate and achievable in its own right, as well as being an important 
part of the bigger strategic goal, i.e. as part of the establishment of electronic health 
records. 
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Lessons learned:  
how to ensure success
Introduction 
This chapter describes key lessons that others have learnt during ePrescribing implementation 
projects and as they have experienced both successes and failures1.
Following in their footsteps, what should you do?
Of course, not all people report the same experiences, and sometimes the ‘Lessons Learned’ can 
be contradictory. However, most of the time, people who have experienced ePrescribing 
1This study of the implementation of electronic prescribing is based on findings drawn from questionnaires 
and interviews conducted with people within the NHS who have experienced the implementation of (or 
failure to implement) ePrescribing within their own hospital settings.
Key messages  
•	 Those involved in ePrescribing implementation in NHS hospitals share many common insights - 
different sites yield very similar ‘lessons learned’.
•	 Traditional project success factors are as relevant to ePrescribing as to any other change 
programme: senior management backing, good project management, user involvement, a multi-
disciplinary team.
•	 Preparation and planning are essential, and take time.  ePrescribing projects need an appropriate 
support network. Champions and ‘little diamonds’ must be found and encouraged, and the 
backing of senior managers secured. 
•	 Identify where current processes are broken and decide what to fix.
•	 Often it is the technology and infrastructure that proves to be the weakest link. These need close 
attention from the earliest days. 
•	 Sell ePrescribing’s benefits widely, but also use this activity to  share problems and doubts early 
on. 
•	 Devote adequate resources to monitoring the system, listen to users feedback and act on it.
•	 Communicate clearly that ePrescribing demands that everyone involved has to be prepared to 
change the way they work, and be willing to learn along the way. 
•	 ePrescribing needs a strong public face, visibility, publicity, strong messages and celebration.
•	 The sequence and pace of implementation needs careful consideration; plan for early success 
and to build momentum.
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implementations tell a very similar story, and seem to draw similar conclusions.
ePrescribing is about change management and the implementation of a sophisticated 
IT system.  There are thus a number of well worn themes that are inevitably  associated 
with implementing any type of information system in a healthcare setting, though 
ePrescribing implementation hospital-wide is probably more substantial than most. 
For example, many people expressed the need for senior managers’ support from 
the initiation of an ePrescribing project throughout its progress, emphasising the role 
of champions, the importance of user involvement and the need for (and problems 
achieving) ‘clinical engagement’. 
These are all necessary conditions for a successful ePrescribing project. However, there 
are also some subtleties that need to be added and placed within a discussion on the 
specifics of the implementation of ePrescribing. 
The thematic approach used in this chapter gives an experiential and reflective, ‘bottom-
up’ view – ePrescribing as seen by the main groups that have to adsorb the new 
technology and release its benefits as they develop new ways of working.
Getting Started: 
“Produce an amalgamated wish list then search out champions.” 
”Think where to start.” 
“Present ePrescribing as a BIG TIME clinical system (not something to do  
with the pharmacy).”
Many respondents had been involved from the start of their hospital’s 
ePrescribing project. Their views, with the benefit of hindsight, were 
often that the ‘vision’ of ePrescribing needed to be established and 
communicated first, both in terms of the big picture (patient safety, 
modernisation, e-health strategy, innovative clinical systems), but also 
in terms of the significant details that would shape the ePrescribing 
system in that particular hospital context. 
Such details include identifying the benefits that ePrescribing offers to the multiple 
stakeholders and which of these benefits are most important to the hospital.  
Is there something positive for everybody? Where are the most receptive parts of the 
hospital? Which specialties can be relied upon to embrace ePrescribing with enthusiasm? 
Which ones, once convinced, will carry the message loudest?  
And which ones will be most problematic?
The vision of 
ePrescribing in a 
particular hospital needs 
to be established and 
communicated first
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“Build up your team. Get the right people, build up your skills, take the time.”
“Get senior people engaged.”
“It’s good to know that the Chief Exec is behind you.” 
“Seek out both medical and surgical sponsors among doctors.” 
An almost universal finding is that ePrescribing projects must be 
multidisciplinary. No single professional group can carry a successful 
system into widespread use. If significant professional groups are 
missing, excluded or unenthusiastic, then this is storing up problems 
ahead. As one project lead said, “Undertake lots of visits and talks, if need be grovel,  
go everywhere and sponsor events. Do everything to build up visibility.” 
An ePrescribing project probably takes two or more years to bring a system into use, 
so the project team needs to contain a committed set of members drawn from a 
number of professional groups. Many of our respondents reported a desire for more 
clinical participation at the outset, in particular from doctors, but they also noted the 
importance of having IM&T members who really understand what is being demanded, 
as well as representatives of other service departments. 
Management backing is vital too. ePrescribing projects will, inevitably, raise some 
resistance, perhaps quite a lot from some clinical quarters. If senior managers are 
anything other than fully supportive, then ePrescribing projects may be wounded or even 
fatally challenged. 
Of course, to attain the backing (and sufficient budget) from senior management 
requires that they are well briefed and confident both of the ePrescribing team’s ability to 
effect the transformation and to deliver real benefits. 
“If possible implement X-ray and lab test ordering before ePrescribing. This helps users 
realise the benefits of electronic orders.” 
This may not be a feasible recommendation in some situations, however, the wider point 
– that ePrescribing is part of a broader programme of implementation of innovative 
clinical information systems, and that success in one area can reinforce success in 
others, should be taken to heart. There is a wider lesson here that all manner of clinical 
professionals need to learn; with new information systems there are some costs in terms 
of comprehensive data entry and more structured work flow, but the benefits do accrue 
and may be seen elsewhere in the most critical areas. For example, time spent entering a 
full medication history will save time, reduce error and facilitate clinical decision making 
throughout the remainder of the patient’s stay.
ePrescribing projects 
must be multidisciplinary
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The build up
“Run ‘road-shows’ on wards and at clinical meetings focusing on ePrescribing benefits: 
for example, legible medication orders and remote prescribing. Sell benefits by 
contrasting ePrescribing screens with the worst examples of (anonymised!) handwritten 
charts that you can find.” 
“Use roadshows also to identify potential ‘showstoppers’ - big problems like difficult 
drugs - before you implement, and keep paediatrics to the end!” 
“Having things like allergy checking or dose checking before implementation can help 
sell the benefits of ePrescribing to senior doctors.” 
Successful ePrescribing implementations are not just multidisciplinary in their project 
team, but also reach out across the range of healthcare professionals both to 
communicate the benefits of ePrescribing and to bring out into the open any fears, 
concerns or areas in which ePrescribing may be problematic. 
The respondents have learned from experience that ePrescribing is 
less easy to incorporate in some clinical specialities, and that some 
drugs have specific regimens that challenge the simple logic of most 
ePrescribing systems. For example:
•	 Paediatric prescribing raises many distinctive problems.
•	 A&E work practices may require that prescribing be undertaken in different ways – 
e.g. using patient group directions (PGDs). 
•	 Medicines such as insulin, warfarin or heparin pose problems of how exactly they 
should be incorporated into ePrescribing procedures.
Many ePrescribing systems, though not all, struggle with variable dosing, so often paper 
charts must be retained. The ePrescribing system should reference these paper charts 
and incorporate key information such as the administration schedule. Removal of all 
paper charts should, however, be the long term goal.
These are all tricky problems, and they have to be addressed. However in doing so, 
and thinking through the ways in which to safely accommodate them in ePrescribing, 
broader confidence can be built up. Certainly the early adopting ePrescribing sites have 
already faced these problems and found acceptable solutions that work. 
ePrescribing is less easy 
to incorporate in some 
clinical specialties
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“Know your kit (hardware, software and infrastructure). Specify, purchase and test – 
allow time to sort out the inevitable problems.”
“Start technical work earlier. You need at least six months: order hardware in good time. 
Get wireless network in place then have an independent check.” 
“Get the infrastructure right. The technology it seems is often the weakest link in 
ePrescribing. You should certainly not assume that your existing IT infrastructure, or 
support services, will be able to cope with hospital wide ePrescribing.”
“Identify and monitor wireless network dead spots: the ‘Bay 4’ problem.”
“Design your WOWs [workstations on wheels, or computers on wheels] to fit available 
workspace; consider issues such as cleaning and storage; check there are enough plugs 
for recharging! You need one WOW for every six beds.”
It may be surprising (or perhaps blindingly obvious) but the most common ‘lesson 
learned’ from this study is that hardware and software are often a problem! 
In particular, a number of the sites studied have had significant problems with their 
wireless networks. These manifest themselves in terms of ‘dead spots’ where no network 
coverage is available (the ‘Bay 4’ problem – meaning the bay at the farthest end of 
the ward). Wireless problems are also seen in underspecified networks that cannot 
cope with the volume of traffic once substantial amounts of prescribing transactions 
are taking place. These kinds of problems are particularly troublesome and difficult as 
they can mean having to withdrawing an ePrescribing system when it has already been 
established on several wards.
Implementing ePrescribing 
“Spot your ‘little diamonds’  who have computer skills and are willing to try new things. 
This could help to determine your choice of pilot ward(s).” 
“Be prepared to change the way you work.”
“Be prepared to lose a few battles.  One new consultant was initially very against 
ePrescribing. He was won over but still doesn’t use it to prescribe!” 
“A surgical sister ‘fought the computer’, saying it was dangerous and she would not use 
it on her ward.” 
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The implementation of ePrescribing requires some quite careful planning and 
reconnaissance. Identifying people who can support and develop ePrescribing is 
important: people who can deal with information and communication technology, are 
happy to change the way they work, and who are enthusiastic about ePrescribing and 
will happily support others. Of course, not everybody falls into this category, and almost 
all sites studied had their stories of resistance. Nevertheless, successful ePrescribing 
implementation can go ahead if there is sufficient support among all the key professional 
groups as well as from senior management. Indeed some of the early dissenters may be 
won round and then become eager converts. 
“Plan, train and work with the system supplier. We say: ‘we don’t do it that way’  
and they are listening.” 
“You need ‘adaptable’ screens’. Pharmacists should be able to adapt screens to  
their practice.” 
“Databases need to be populated and software configured. This is a way to make it 
attractive, for example if surgeons’ protocols and order sets are set up from day 1. 
These ‘goodies’ can save people’s time and help them to appreciate ePrescribing…If a 
substantial part of this work is not done at the beginning there will never be enough 
staff and resources later.” 
“Decision support implemented at the time of ePrescribing implementation would  
have been of great benefit and would make the system better to ‘sell’ to  
professional colleagues.”
Building a good relationship with software and database suppliers is important. In the 
early set-up phase of an ePrescribing project, interactions with suppliers can help to solve 
problems. Tap into other sites with previous experience of the same software. That said, 
in order to take ownership of the system, and make it fit into the specific context, staff 
will need to work on configuring the software and making it look and feel appropriate 
for their needs. 
This work takes time, and to some degree there may be options as to how much is 
undertaken ahead of roll-out. That is, a basic system might be rolled out sooner, and 
extra functionality added to it as time goes by. However, in order to provide the most 
positive experience of ePrescribing for new users attention to providing as rich a set of 
features as possible in the initial roll-out is recommended. This is a question of degrees, 
and it is certain that any successful ePrescribing implementation will continue to identify 
and implement changes as experience with the system is gained and as requests are 
made for changes and new features.
Challenges and lessons learned PAGE 37
CHAPTER 4Lessons Learned: How to ensure success
“Have a dedicated team for training and support.” 
“Budget for double the training manpower than you first thought of.” 
“Training must be not too early, and not too late.” 
“Training is for two purposes: to understand how ePrescribing works, and  to build 
confidence to do the necessary tasks.” 
“Training is straightforward but you need at least three people and it needs to be  
24/7. For nurses, emphasise experiential learning and FAQs (frequently asked questions), 
not lectures.”
“Nurses are good as ‘clinical’ trainers for ePrescribing but still need a pharmacist to 
support doctors in early stage.” 
“Essential to have clinical staff involved in training and implementation.” 
Training people to use ePrescribing is necessary. However, opinions differ somewhat 
as to how much training is needed, and the extent to which it should on the job, or in 
the classroom. Classroom training is useful, but only if the classroom is suitable with 
equipment and software that is the same as in use on wards and in clinics. The counter 
argument other people make is that if a system is sensibly designed, and if staff have 
sufficient IT skills, perhaps from using other clinical systems, then the amount of training 
needed should be minimal – just training to deal with site-specific elements such as  
log ons, passwords etc. 
But training has other roles than just imparting necessary information. It can build up 
confidence, reveal concerns or pick up important bugs or problems with a system. For 
this reason trainers are an essential element of the ePrescribing team – not just teaching 
the system, but also feeding back changes to make it easier to use. 
Training, of course, lasts for the lifetime of the system. Sites with a hospital-wide  
system in use maintain a fully staffed training team to ensure that everybody has  
access to appropriate information and support. New staff arrive, locums can appear  
late at night and at weekends, new upgrades of software are made regularly, systems 
are improved and changed, and experienced people may need refresher training or 
training for new roles. Training responsibility is usually combined with the technical 
and clinical responsibility for support and development of the system, allowing trainers 
to pick up and respond to all manner of concerns and needs that are revealed during 
training activity. 
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“Quick roll out to minimise ‘messiness’ of two systems running in parallel. Remember, patients are 
often transferred between wards.” 
“Think through the sequence of implementation by ward/specialty. A ward might take a team of 
two or three pharmacists to re-enter data from paper to computer over one or two days. Clean up 
the data first, not during transfer.” 
“Keep extra staff available at ward level for the first one or two days of drug rounds.” 
“Roll-out requires intensive support with at least four full time trainers available to ‘walk round’ 
with staff on all drug rounds. Essential to provide support 24 hours a day.” 
“Given that the IT must work, the helpdesk has a critical job to do. It must be staffed accordingly.”
Those who have implemented ePrescribing across hospitals are 
almost universal in their view that, once a system has been set-up 
and tested in one chosen area – perhaps one or two wards that have 
particularly supportive staff, then the full implementation should 
proceed quite fast. There are two reasons for this. First, because 
having two systems (paper and ePrescribing) in use in the same 
hospital makes a lot of work when patients cross these boundaries, 
and second because it is probably less safe. The sequence of this roll-out needs careful attention, 
perhaps starting with those that are keen, but also incorporating some of the tougher challenges 
early on to show commitment.
In any case, almost all sites studied acknowledged the need for a number of dedicated staff to 
support ePrescribing going live in each location, converting medication orders from the old to the 
new system, providing on the job training and support, and picking up other nursing tasks when 
ward staff take time to learn to use ePrescribing.
“Get help, perhaps co-implement across hospitals, sharing experienced staff for the critical periods.” 
“Celebrate and publicise with posters and a party... ’This is an ePrescribing ward!’” 
A number of sites have used locum pharmacists and extra nurses to bolster the staffing levels 
during ePrescribing implementation. In any case it is probably sensible as far as possible to minimise 
any other changes or innovations underway during the ePrescribing implementation period. One 
suggestion from an experienced site was to draw staff from other local hospitals during the key 
change-over period. In this way experienced people are available, and mutual learning can occur. 
This will be even more useful if local hospitals are also on track to use the same or similar software 
in their ePrescribing plans.
Finally, ePrescribing needs to be celebrated. Among the strategies reported by respondents were 
ward posters, tee shirts, and a party.
Once a system has been 
set up and tested then 
full implementation 
should proceed quite fast
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Systems in Use 
“Keep up the level of support for months after all is live. Problems still emerge and must 
be fixed - mostly technical or networks.” 
“Identify and sort out the quick fixes as soon as possible. Always acknowledge  
problems and listen.”
“Keep user groups going: it is very important to keep user groups going to ‘get the 
moans’ and update the list of FAQs.” 
“Have 24-hour IT support on call.”
“Encourage ‘warts and all’ user feedback. Keep staff informed about potential problems 
as well as potential advantages.”
“Provide rapid and sympathetic response to user problems.” 
”Encourage staff to report/feedback problems.” 
“Reports generated by the ePrescribing system could be used to ‘demonstrate quality 
for the trust’; generate time and motion data on ward activities, and audit antibiotic 
prescribing issues.” 
Experience of starting to use ePrescribing is generally that there is an initial period of 
intense activity and support, with mixed reactions by clinical staff, followed perhaps after 
two or three months by a more positive feeling, and after six months by the start of a 
feeling of “I would not want to work without ePrescribing”.
Nevertheless, support activity continues to be needed throughout 
the life of a system. Problems will keep on emerging as well as new 
ideas for improvements and new understandings of the possibilities 
ePrescribing offers. Trainers or other designated people still need to 
be working to pick up people’s concerns and suggestions, and then 
do something with them. An active and positive support system that 
feeds back progress on fixing bugs, implementing new features or 
just answering questions is an important part of sustaining ePrescribing,  
and the basis for obtaining the full benefits.
For example, in the early stages of ePrescribing use clinical staff are unlikely to think 
about the management potential of the data held by the ePrescribing system. But a 
year later, when available data is substantial and covers a period of time, then reporting, 
trend analysis or safety audits may become attractive additional system benefits.
A support system  
that feeds back on 
progress and answers 
questions can help 
sustain ePrescribing
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Supporting ePrescribing will usually be a task that demands a mix of skills, some IT 
related, some clinical, and some specific to pharmacy. How to set up and staff such 
a support operation is not straightforward, and things will not work well if technical 
questions go to clinical staff or vice versa.  ePrescribing sites solve this problem in 
different ways, but perhaps the most successful is to have a team approach with clinical 
and technical staff working together.
“Pharmacists’ work will change: prescribing is better so pharmacists need to make  
fewer interventions.” 
“Pharmacists work in a different way here...ePrescribing has made us more clinical.”
“Avoid using agency staff as far as possible. Instead, create a ‘flexi-bank’ of trained  
part-time staff.” 
“You will get greater control over dispensary workload: but workload may go up and 
ward staff will expect faster turnaround time for discharge prescriptions (TTOs).” 
“ePrescribing can have major benefits for stock control. Both nurses and pharmacy 
workers have a better picture of use, and can quickly request supplies, e.g. by email. 
Result: a 10% work load reduction in pharmacy.”
ePrescribing has consequences. Some of these are directly related to the benefits 
that they offer. For example clear, legible and complete medicines orders mean that 
pharmacists need to spend less time making simple corrections, they may also spend less 
time supporting the supply of medicines. 
On the other hand the work involved in supporting the ePrescribing system – keeping 
it up to date, improving usability, implementing prescribing policies etc, will probably 
eat up, and may well exceed (depending on pharmacy’s role), the time savings created 
elsewhere. This may also lead to some consequential changes. For example, if orders are 
sent direct to the pharmacy, then expectations will be that they are processed directly. 
Meeting such enhanced expectations may not be so easy. There may be other situations 
too where there are unrealisable expectations of immediate response. 
ePrescribing has consequences for staffing. For example, agency nurses or doctors that 
have not been trained to use the system are less useful. A number of ePrescribing sites 
explained that they had been more eager to build up a bank of part-timers who were 
trained, had their own passwords, and could use the ePrescribing system directly.
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Wrinkles and other observations 
“Patient Group Directions [medicines that nurses can give without an individual 
prescription, e.g. for analgesia and aperients] do not work well with this ePrescribing 
system. PGDs are used a lot in A&E .”
“Take care with ‘stat’ orders: e.g. furosemide [same example given at a number of sites]. 
There is no stat alert in the system so staff still need to talk, i.e. tell nursing staff you 
have ordered a stat dose.” 
“Nurses need decision support too, e.g. BNF lookups while doing drug rounds.” 
“Once a day orders - take care as they may be scheduled to be 23 hours hence.”
The number and type of wrinkles will be dependant both on the system being used 
and the way in which it has been implemented. Whilst some issues will be pertinent 
to all – problems with stat doses and delays to the administration of first doses due to 
scheduling are commonly reported – others will be more locally specific.
These types of problems are likely to be well known to individual users of a system 
and may lead to workarounds being developed. It is important that these wrinkles and 
their workarounds are actively sought and listened for. Understanding what is not quite 
working, what is irritating people, or what might cause error, is an important job of the 
ePrescribing team and this understanding should be one of the primary drivers for future 
development efforts.
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Making ePrescribing safe  
(or dangerous), then safer
Introduction 
We reported earlier that the reduction of medication errors and hence Adverse Drug Events 
(ADE) is the main reason why ePrescribing is introduced.  In this chapter we raise some of the 
issues that are important to consider if a system really is going to deliver on the promise of 
reducing ADEs.
People often ask if ePrescribing is safe and reliable - the honest answer is that it is as safe and 
reliable as you make it.  It is highly likely that the system you are introducing is being used safely 
and reliably elsewhere, however it is the responsibility of everyone to ensure that the system is 
used safely in your hospital. 
In this section we pass on some of the advice we have been given, and ways in which others 
have learned, often the hard way, how ePrescribing needs to be introduced if it is to be used 
safely and reliably. One person we interviewed said:
“The mistakes are all out there, in the literature, but you have to make them yourself to learn.”
Key messages 
•	 Any ePrescribing system is as safe – or as dangerous – as you make it.
•	 The minimum should be to introduce an ePrescribing system which is at least as safe as the 
current paper system.
•	 Preliminary work is required to build comprehensive databases and develop sensible rules to 
support users and help ensure safety.
•	 ePrescribing systems must not mislead prescribers as to the level of support or checking that 
they provide.
•	 Measuring the baseline of the old system and then re-measuring  can help build confidence and 
ensure safety.
•	 Running parallel systems is inherently unsafe. Change over from paper to ePrescribing should  
be swift.
•	 The really significant safety gains from ePrescribing come from continually developing the 
system, and using information provided by the system.
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We hope to save you going through this by passing on advice from others and linking 
ePrescribing to general safety thinking. These lessons are here to protect patients, to 
protect you and save you time. We have heard several anecdotal cases, from the UK and 
from abroad, of patients harmed as a result of the introduction of ePrescribing. While we 
think this is very rare, it illustrates the importance of safe implementation. 
Safety is often, correctly, described as a ‘systems issue’.  The ‘system’ here is not only 
the ePrescribing system, but everything that humans do to it, and the way in which we 
all work with each other and with the ePrescribing system.  Once the whole is up and 
running, it is important to keep refining the system and making it safer.
Before implementation 
There is an old saying in computing – ‘Garbage in, garbage out’ - which illustrates the 
importance of first building up the drug database that will be used for ePrescribing.   
This may be developed from the current pharmacy database (although it will probably  
be quite different), or obtained from a third party source.  Here are some tasks that need 
to be done:
•	 The data files must be double checked for accuracy.
•	 There needs to be work to ensure all prescribable items are on the database (for 
example oxygen is easily forgotten). 
•	 Quite a bit of work can be done at this stage to implement Drugs and Therapeutics 
Committee policy, for example by restricting the access of certain classes of 
prescribers to non-formulary drugs, or for using the drug off-licence. 
•	 It may be necessary to consider whether certain items would be safe if prescribed 
using paper charts during preliminary stages. As we discussed, any specific 
ePrescribing system may not be appropriate for drugs which need frequent dose 
adjustment in response to physiological monitoring. Warfarin, heparin, insulin and 
intravenous fluids are common examples, but your hospital may have other ‘difficult’ 
drugs to add to this short list.
•	 Although some actions will definitely need to be done with the ePrescribing system, 
there can be a lot of flexibility in who does what when.  Introducing an ePrescribing 
system is a good time for staff to try to rethink how they work, and how they can 
monitor their work.
Setting sensible rules
One of the ways in which computers improve safety is by setting rigid rules that cannot 
be broken.  This can also be a source of error too, for example some systems link the 
dose form to the route of administration, to stop oral liquids being injected.  This can 
cause problems on occasion, for example vancomycin injections can be prescribed orally 
in practice, and the ePrescribing system must not block this sort of need.  These kinds of 
problems have often been experienced by ePrescribing sites, and can be anticipated and 
built into the database and rule sets before implementation.
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Another common source of errors can be addressed at this stage 
by considering the order in which medications are listed. Most 
systems allow the prescriber to type in a few letters, and a menu of 
drugs starting with those letters will be shown in alphabetical order, 
usually in a long list which shows every formulation of each drug. 
It is common for prescribers not to read to the end of each line and 
hence pick the wrong formulation (and sometimes the wrong  
drug, such as penicillamine instead of penicillin). 
“One example I keep remembering is methotrexate which was prescribed every 
day.  I thought that’s wrong, straight away, fair enough.  But when I went into it 
I couldn’t understand why they were on methotrexate and it was supposed to be 
methotrimeprazine.  They were next to each other on the look-up.” [Pharmacist]
One hospital identified many selection errors where ‘paracetamol 
500mg soluble tablets’ were selected instead of ‘paracetamol 500mg 
tablets’, as the ‘s’ of  soluble made it come before the ‘t’ of tablets 
on the  alphabetical list. By altering the list so that the ordinary 
tablets were listed first, the problem was resolved.  A similar problem 
has occurred with suppositories being prescribed instead of tablets.
Establish a baseline
“More resources - especially staff time - before implementation would have been useful, 
to do baseline audits on medication errors, time delays etc to quantify impact of the 
system.” [Pharmacist]
It is very helpful to measure the effectiveness of the paper system, 
before introducing the electronic one. ePrescribing can lead to 
existing errors becoming more visible (for example, by showing red 
exclamation marks on a screen), hence people can believe the system 
is more dangerous when it is not. At one site this led to a consultant 
demanding the system be removed on the basis of safety. However, because the manual 
system had been audited beforehand, it could be shown that the electronic system was 
indeed safer, he had just never realised how unsafe the paper system had been. Here are 
four baseline measurements that are easy to do:
Rigid rules that cannot 
be broken can improve 
safety – but can also be a 
source of error
Consider the  
medication listing order 
in the drug menu
ePrescribing can lead to 
existing errors becoming 
more visible
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•	 Missed doses on drug rounds (do this by getting nursing staff to record more 
carefully than normal). Find the number and the causes why missed (no drug on 
ward etc).
•	 Prescribing errors.  These can be found by the clinical pharmacists recording them 
when on their rounds.
•	 Legibility. What proportion of drug chart entries are illegible or open to 
misinterpretation?  Photocopy the worst to show when introducing ePrescribing.
•	 Number of missing drug charts.
These studies can sometimes be done in partnership with local universities and can 
certainly be an opportunity for enthusiastic staff to develop their own understanding of 
ePrescribing’s role in promoting patient safety.
Checks and checking
There is a widespread perception that ePrescribing increases safety by introducing 
decision support such as allergy checks, interaction checking, linking to relevant 
pathology data etc. These can all deliver benefit, but may also cause harm if not 
implemented or used properly, or if people are unsure if they are available.  
It needs to be decided early on whether any of these types of 
decision support can be delivered safely and reliably in the initial 
implementation, and not automatically assumed that these features 
should be implemented.  However, if not implemented, this needs 
to be made very clear during prescriber training.  Some hospitals are 
very good at this, but we have found others in which the prescribers have become less 
careful (e.g. stopping checking in the BNF doses or interactions they were unsure about) 
because they assume that the system will spot any mistakes they make.
“…pick up a BNF, go through the pages, look at the back. That takes time. Meanwhile… 
people around are doing their job, and it looks as if I’m just sitting reading a book when 
I should be working…The computer gets the job done quickly.”  [Junior doctor]
Resources and commitment
The implementation of ePrescribing needs to be suitably resourced, otherwise it can pull 
staff from other safety-critical activities. 
“ Have lots of hands and floaters about…We had extra nurses on duty for the roll-out as 
the drug rounds took ages and the rest of care would be left.” [Nurse]
 
Decide on specific  
checks and decision 
support early on
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There need to be procedures so that patients can still receive drugs, 
and be prescribed them, if the whole system crashes.  These backup 
procedures need to be put in place, and tested, for every system 
software release and hardware upgrade. Testing these procedures is a good way 
to build confidence in the robustness of the ePrescribing system and can reveal 
problems such as printouts that are hard to read or take hours to print, and/or 
distribute to the wards. 
“If it’s planned, the paperwork comes up, we have notification that the system will 
go down. If we are lucky it will be after you have done your big ward but if not all 
the paperwork comes up and you get a backup system which you then use and you 
file in the notes.  Then the computer girls go back and put all the drugs back in.” 
[Nurse]
“I’ve seen events where you think, oh gosh – that was lucky. You know what 
patients are like: ‘I haven’t had anything for the pain for ages and ages’ and the 
system has gone down and luckily a nurse has remembered they had…something 
half an hour ago. It’s a nightmare if the system comes down and you are on call.  
Everyone talks about it.  It can be down for three hours and it is the worst thing  
that could possibly happen.”  
[Junior doctor]
The first few days... 
“Use one unit as a pilot. Audit to ensure systems can be streamlined before  
mass roll out.” [Pharmacist]
“Have trainers and support on hand wandering the wards to troubleshoot.  
Have comments sheets to correct any problems as soon as possible.” [Nurse]
Do not be afraid to close down the system if there are serious concerns about its 
safety.  It is not unusual for the first roll-out to fail; some sites never recover from 
this, but most are able to be successfully rolled out a few months later (one of the 
purposes of this guide is to reduce the chances of a failed initial roll-out).  
“Once system was launched, support…fell on the IT support team out of hours, 
who have great knowledge of the system but less of the medical aspects. Time is 
everything; system should have been thoroughly checked before launch with some 
‘dummy patients.” [Pharmacist]
“Need 24/7 technical support for troops on the ground.” [Senior doctor]
Test system  
crash procedures
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Many of the comments elsewhere about implementation also impact directly on safety.  
For example, substantial 24-hour support (professional and technical) is required seven 
days a week during roll-out and beyond. People need to be available to guide and give 
advice. While initial, pre-implementation piloting will have been done, only so much can 
be achieved before going live, and it is inevitable that final testing must be on  
the live system, and therefore there must be plenty of informed, able staff on hand to 
trap problems as they occur. ePrescribing will reduce some risks but introduce others,  
so be alert! 
“Staff will always choose what they are familiar with so will try to keep the paper going 
when it gets tough. Don’t let there be any paper left after the roll-out, not even for 
emergencies.” [Nurse]
At some point the paper prescriptions of existing patients on the ward will need to 
be transferred to the electronic system. This stage has potential for error, and should 
be checked by a second person. The transfer from drug chart to computer must be 
absolute and undertaken quickly; a ward cannot have both ePrescribing and drug chart 
prescribing at the same time, as this is dangerous.  Having said this, some paper may be 
inevitable; some ePrescribing systems are unable to cope with absolutely all items that 
need to be prescribed. In these cases there may remain paper systems for some of the 
most dangerous drugs such as warfarin, heparin and insulin. Prescribing of intravenous 
fluids can also be problematic.
“Before, you might have written up saline and say OK, run a couple of hundred mls in 
fast and then slow it down a bit and then if the blood pressure comes up, run it over six 
hours, and if the blood pressure doesn’t come up then run it over two hours.  A rigid 
system doesn’t allow you to have that flexibility.” [Senior doctor]  
This mixture of both an electronic and paper system is in itself a risk 
factor. Transferring these paper systems to computer will also be 
a risk factor, and techniques such as the use of dummy drugs on 
the ePrescribing system (described in chapter 7) need to be used to 
ensure that doses are not missed.
Technical limitations and failures can have safety implications.  
For example, if the wireless network does not cover all beds, data ends up being written 
on scraps of paper and entered, with variable accuracy, later. 
The transfer from drug 
chart to computer must 
be done quickly
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Continuing development 
In this section we describe some common issues, and finish with a short comment  
on how the safety of ePrescribing can be improved, and how ePrescribing can  
improve safety.
“The support required is far greater than anticipated.” [Pharmacist]
“Can’t have too much - especially visible support early on.” [Senior doctor]
“It’s phased plate spinning.” [Nurse]
Once people become dependent on ePrescribing there needs to be constant availability 
of support, 24/7/365.  There must always be more than one person, usually in each 
profession, who fully understands the system, in case of holidays, illness etc. A good 
training programme and provision for locums etc. must be maintained.
 
In some areas you can use the computer’s reporting ability to identify problems and 
incidents and monitor progress. 
Hardware and software can still raise issues:
•	 Active replacement of faulty or worn out equipment must be budgeted for.  If wards 
have to pay for their own equipment they may prioritise other issues first.
•	 Faulty keys on a keyboard (such as keys which stick, or do not always work) can lead 
to error, for example by adding an extra ‘0’ to a dose, or missing a decimal point.  
We heard of one keyboard, still in use, which had had a faulty key for nine months.  
•	 Batteries may need replacing in laptops; in one ward staff were unplugging a 
computer on wheels, then running with it down the ward to plug in again to see 
another patient, before the computer closed down through lack of power. 
•	 Software can also be a problem.  One site which had a system for some years  
found it could not access or read the notes of the first patients put on the system,  
as a recent software release had made the old files unreadable.  New software 
releases always have to be treated as a potential risk, with staff on alert to spot 
unexpected consequences. 
ePrescribing systems mean that patient information can be accessed without seeing the 
patient. In some cases this has reduced time and activities spent with the patient. For 
example, in some sites pharmacists predominantly check prescriptions without seeing the 
patient. This reduces the information available to them, stops them checking on things 
such as intravenous drug delivery, and reduces their communication with the patient.
The system needs to be easily used by occasional users. There is a risk that those who do 
not regularly use it, such as some senior doctors, may lose their ability to use the system. 
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Once the system has been introduced and reached some form of stability, there will  
need to be continued changes and updating, and as a consequence there needs to be  
a quality assurance process in place to oversee this. 
Improving the safety of healthcare is not a one-off task, it is a continuous process.  
ePrescribing will really improve safety when and if this constant development  process  
is in place. This in turn implies good constructive partnerships between users and  
with the suppliers.  
The essence of improving the safety (and quality) of a system is simple: decide what 
matters, measure it to see how well (or badly) you are doing and, if you do not like the 
result, introduce improvements, then re-measure. Has it worked? If not, repeat using 
different improvements; if it has worked, move onto another area of importance.  
An understanding of this process is important for two reasons.  First, it can help make 
the use of ePrescribing safer and help over time to build stronger confidence in the 
system.  Second, ePrescribing can provide data which allows things to be studied that 
could not be measured, or measured easily before.  This is the beauty of ePrescribing; it 
offers a much safer future for patients.
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Planning for ePrescribing 
Introduction
ePrescribing systems are delivered by a multidisciplinary project team. 
Membership of this team needs to include doctors, nurses, pharmacists and Information 
Management and Technology (IM&T) professionals as a minimum, but also probably allied 
health professionals, estates staff and others. Experience indicates that the more clinical 
participation at the early stages, the better. Clinical staff, in particular senior doctors, both 
physicians and surgeons, are needed to communicate with their own professional groups 
and to represent these groups’ interests as ePrescribing is planned.
Key Messages 
•	 Planning for ePrescribing needs to be done by a multidisciplinary team, and team members must 
maintain links back to their professional and operational groups.
•	 This team has  primary responsibility for developing a vision for ePrescribing that can be 
communicated to the wider community.
•	 The ePrescribing team should look beyond their own institution, and talk to and visit other sites 
using ePrescribing, as well as software suppliers.
•	 ePrescribing can share infrastructure and technical resources with other information systems; but 
there is no free lunch. 
•	 The ePrescribing team will need to specify and procure software, database and technical 
infrastructures for ePrescribing. This takes time.
•	 The ePrescribing  team must think through the various changes in work practices that 
ePrescribing will necessitate, and monitor such changes once it is in use.
•	 Thinking through the sequence of pilot testing and rollout is essential. Many subtle decisions 
and trade-offs will need to be made.
•	 Technical and clinical support is needed during the roll out phase, and much of this support 
needs to be retained for the operational life of the systems.
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The ePrescribing team must be multidisciplinary for two reasons. 
First, because ePrescribing demands multiple professional inputs into numerous 
decisions about how the system will work. ePrescribing is a real-time clinical information 
system that cuts directly across multiple professional domains and closely supports care 
pathways and the patient journey and this poses distinct challenges. As a consequence, 
a premium is placed on joint commitment and active involvement in planning new ways 
of working. 
The second reason for the team to be multidisciplinary is because 
people can make or break an ePrescribing project. ePrescribing will 
challenge all healthcare professional groups to consider their current 
practices, identify weaknesses or inefficiencies, and to be prepared 
to change. This can lead to resistance, fear or feelings of loss of 
control or status. A well constituted project team, with the right 
people connected to the right communities, can do a great deal to 
overcome such concerns. 
If there is understanding, communication and commitment, then many good things are 
possible. If there is the opposite – ignorance, isolation and doubt – then the likelihood 
of failure is increased. Put another way, professional interests must be understood 
and respected, and the best way to achieve this if to have them represented in the 
ePrescribing project team. 
The team’s agenda
The ePrescribing team has a substantial agenda to address: scoping and scaling the 
ePrescribing system that is appropriate to the particular site, communicating with the 
user community and establishing a vision and mandate for the system. 
They will lead the tasks of analysis and design that must underlie the new work 
processes for medicines use and they will also be responsible for the detailed project 
management activities required to deliver the various elements of ePrescribing on time 
and to budget. Finally, this project team has to oversee the process of moving from 
the previous, probably paper-based, system to the new system, managing this change 
against clear criteria of safety.
Experience in the UK suggests that between one and two years in 
planning is appropriate before live use when commercially developed 
ePrescribing software is being used. The main tasks that need to be 
undertaken in this period include:
ePrescribing will 
challenge all healthcare 
professional groups to 
consider their current 
practices and to be 
prepared to change
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•	 Working to secure wide stakeholder commitment.
•	 Establishing and communicating the vision for ePrescribing and its relationship  
with wider strategy.
•	 Building and sustaining links to senior management and clinical leaders.
•	 Talking to other people and other sites that have experience with ePrescribing.
•	 Specifying, selecting, procuring and installing software and equipment.
•	 Configuring software and building required databases.
•	 Establishing the changes in work practices that are necessary, desirable and safe.
•	 Establishing training and support resources.
•	 Collecting baseline data against which to monitor implementation outcomes.
•	 Identifying pilot sites and the roll-out sequence.
•	 Continuing to ensure that ePrescribing is an actively managed system, with ongoing 
support and a development trajectory.
Successful ePrescribing implementations are planned carefully and undertaken in parts 
that can be implemented swiftly and demonstrate benefits soon. Over-ambitious plans 
can prove un-implementable, while under-ambitious systems might not reveal benefits or 
may exhaust commitment. A related problem is the dead-end sub-system which works 
very well for limited functions but offers no route forward and cannot be integrated with 
other systems – e.g. a stand-alone discharge prescribing system. 
Scoping and scaling the project
ePrescribing projects vary in their scale and ambition. They range from introducing 
systems that embody the whole medicines use process on the scale of a whole hospital, 
through to systems intended to support a specific clinical specialty, or systems that are 
just focused on one part of the medicines use process such as prescribing, administration 
or discharge. A ‘whole hospital’ project is different in scope and scale to smaller pilots, 
but might in some ways be easier to manage and safer too – fewer handovers or 
multiple systems in use. Put another way, integration of ePrescribing with the overall 
clinical work flow is a challenge, but also is the basis of the benefit.
The wider scale (whole hospital) and wider scope (whole 
medicines use process) is certainly desirable in order to exploit 
the possibilities for improved and safer care. The biggest 
benefits of ePrescribing for a hospital or trust come from 
wide-spread use in joined-up care giving. Fragmented or partial 
use, and lack of care continuity, at best dilute the benefits and 
probably lead to new risk. Limited approaches may also undermine the economies of 
scale in the support and infrastructure needed for ePrescribing – for example in justifying 
the required training and technical development resources. Experience suggests that 
systems that only serve one part of the medicines use process, for example handling 
The biggest benefits of 
ePrescribing come from 
widespread use in  
joined-up care
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discharge prescriptions (TTA), while offering an ‘easy’ entry into ePrescribing also 
represent a potential dead-end that offers no strategic route forward  to integrate 
ePrescribing with other systems and work practices.
Having a vision of a whole hospital, whole medicines use process system is important, 
but that is not to say that this is achieved all at once, or that there may not be good 
reasons to make specific alterations, adaptations or refinements to reflect a particular 
context. For example, in some areas of care (e.g. critical care, oncology) there may 
be sound reasons to choose and use specialist systems that are different from those 
designed for more general implementation. Nevertheless, these kinds of development 
need equally to be seen as part of this vision.
Integration
ePrescribing systems can be, to degrees, more or less integrated with other clinical 
information systems that are in use or are planned. Integration here meaning sharing 
data with other systems: both using data – e.g. patient demographics from a patient 
administration system (PAS), or providing data e.g. inpatient medication orders 
transferred to a discharge system. Integration can also be seen from a user’s perspective 
as meaning that electronic resources appear as a ‘single system’, with for example a 
single login and a consistent user interface across various applications – for example, 
PACS, ePrescribing, PAS, pathology reports. 
The aim of almost all hospitals is for an integrated approach, and such data sharing and 
a common interface for users are central for delivering the NHS Care Record Service. 
However, when ePrescribing is being planned, and as the choice of software is being 
made the question of how such integration will be achieved, how soon and using what 
technical means, is a key issue. 
Specifying and selecting software 
In most cases, an ePrescribing team has to make a choice as to what software they 
purchase, there being a number of system suppliers active in the UK marketplace. 
This decision needs to be carefully approached on the basis of a full analysis of needs, 
functional requirements and constraints. It is beyond the scope of this report to discuss 
good procurement practices in detail. But among the specific issues that the ePrescribing 
team will need to consider are:
•	 The existing systems and databases in use with which ePrescribing will need  
to interface.
•	 The technical infrastructure and devices that may be shared with the new system.
•	 Reference sites offered by various suppliers or identified independently.
•	 Peak transaction loads expected and their consequence for databases and networks.
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The ePrescribing team will probably want to asses some areas of functionality in detail 
for which purpose the ePrescribing functional specification for NHS trusts (2007)1 
prepared by NHS Connecting for Health makes a useful starting point, particularly  
the functional requirements given in the mandatory/essential category.
The experience of some UK sites suggests that building a good relationship with the 
software supplier is an important factor in successful systems implementations. At an 
early stage the project team needs to start to assess this, for example investigating other 
sites that use particular types of software, and seeking information on how supportive 
the supplier is during implementation and how responsive they are to change requests 
and reported system faults.
Thinking through work practice changes 
One key responsibility of the project team is to think through the various changes in 
work practices that ePrescribing will necessitate, and how this relates to the functions 
of the ePrescribing software and the equipment that is available. For example, a work 
process that assumes that all doctors have immediate access to a computer may not 
work if they do not. 
Among the issues that will need to be considered are the details of changes in 
professional roles, details of timing and durations, and questions of where work is 
undertaken. Here are a few examples of such issues that need to be addressed by 
the relevant professional groups; in few cases can the answers to these questions be 
provided by just one group.
•	 Who will enter medication orders into the system during ward rounds? Traditionally 
this has been the job of junior doctors, but in at least one hospital the ward 
pharmacists join the round and undertake this task.
•	 It may not make sense to schedule medicines rounds at the time of staff changeover. 
Tradition might indicate an 8pm round, but if this round is inevitably delayed by staff 
changeover the system may treat these doses as delayed or missed doses.
•	 How will the possibility of off-site prescribing be managed? Can any authorised 
prescriber do it? Under what circumstances? 
•	 What effect will the electronic transmission of discharge prescriptions have on the 
organisation of the pharmacy?
•	 Should ward pharmacists use remote access to the medication record to undertake 
checking (screening) and to prioritise their ward activity?
•	 Can the data in the ePrescribing system help support a more efficient or timely 
medicines supply process, and if so how?
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There is also a need to work out what configuration of hardware devices will be needed 
by each ward or clinic (e.g. what combination of fixed workstations, workstations on 
wheels (WOWs), tablet computers, PDAs etc.), including standby and backup devices. 
Considerations include the type of work activities and their intensity (e.g. ward rounds 
and their frequency; whether access to information is also needed  for a teaching role, 
periods of peak activity), as well as practical space considerations. For example, where 
will five mobile trolleys fit on a ward? At the same time, it is necessary to think about 
how replacements and upgrades will be funded once the implementation of ePrescribing 
is over, and any special project funding is no longer available.
What choices are available to structure the planning of the 
roll-out of ePrescribing? 
As with other information systems projects, ePrescribing can be rolled-out in a number 
of different ways. Among the elements of choices are:
•	 A pilot site – perhaps one or two wards or clinics – where software, equipment and 
re-designed work processes can be tested out.
•	 Parallel running, where a new ePrescribing system is run alongside an older system 
for a period of time to validate its outputs.
•	 Incremental implementation in which a system is launched with limited functions, 
and further functions are added over time.
•	 A big bang, where work is moved in one swift activity from old system to the new. 
All of these approaches can be a part of an ePrescribing plan, although parallel running 
should be very carefully evaluated since parallel systems, far from enhancing safety, can 
introduce new opportunities for error and certainly put an additional load on those who 
have to do everything twice.
A sensible approach, as adopted by a number of the UK sites studied for this report, is 
to include a pilot site running for a period of two or three months, followed by a swift 
roll-out across the rest of the hospital – not quite a big bang, more rolling thunder - but 
certainly a speedy move from paper to ePrescribing. 
The impetus to do this faster rather than slower is to minimise the period of time in 
which people and patients have to cross the boundaries between one way of working 
and the other. There is also the possibility of other parallel change programmes 
going on. By limiting the period of this change, it is possible to limit the problems of 
interference between different change initiatives.
 
Within any approach there will almost certainly be some incremental implementation 
too. For example a function such as enforced allergy checking may not be part of the 
initial roll-out, but can be implemented in a second or subsequent phase.
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Support services
What ever the decision on how ePrescribing is rolled out, the period 
of initial use will require extra resources. The level of availability of 
these resources will influence how fast the roll-out can be. With more 
spare capacity, including in particular nurses and pharmacists, a faster 
rate can be safely sustained. Equally, there needs to be coverage in 
depth by the technical support team at this time. Experience suggests that at ‘go live’ the 
most annoying and debilitating bugs can emerge. For example, in one UK site it was only 
on go live that it was discovered that there was an arbitrary limit on the number of log-
ins to the system, dictated by the size set for a file. This was easy to fix, but only once it 
was diagnosed. System testing and pilot site usage will reveal some such problems, but 
it cannot reveal all of them, so a rapid and intelligent technical response may well be 
needed.
Training, too, will peak at the time of changeover, and must be planned to make  
sure that it is timely (not to early, not too late) and delivered in an appropriate way. 
However, both technical support and training will continue to be required throughout 
the life of a system.
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Managing ePrescribing in use
Moving to ePrescribing 
“People are naturally wary of change.” [Nurse] 
“The most advanced hospital computer system in the country!”[Junior doctor] 
Switching from a time-honoured paper system to ePrescribing is a big step.  
Staff not actively involved in the planning process may feel a sense of pride, but  
will also be anxious about what the change will mean for them, and how well they  
will cope with it.1
Key messages 
•	 ePrescribing brings benefits to nurses, pharmacists and doctors in terms of access to information 
and helps them to plan and to organise their work. 
•	 In terms of changes in professional role, the benefits and risks may be greatest for pharmacists. 
•	 Training and support for ePrescribing is needed round the clock for as long as ePrescribing is in 
use. The provider(s) of this training will vary – different departments take it on at different sites - 
but it is essential to have clinical staff involved. 
•	 ePrescribing forces a structure onto routine tasks, making them more rigid. While staff 
performing the task will be well aware of this, colleagues in other professions may not 
appreciate the extent to which particular tasks (such as doing a drug round or writing or 
screening a new prescription) have changed. 
•	 Staff using ePrescribing will develop workarounds; ways to get the job done. Some groups 
of staff will also start to configure the system to meet their particular needs. These ad hoc 
developments need to be monitored and discussed with staff. 
•	 Mobile technology used for ePrescribing raises handling, security, storage and infection  
control issues. 
•	 With experience, people may expect to get reports from information inside the computer 
system.  Often this is not easy and data analysis facilities may be restricted to a small number of 
staff with specific technical knowledge. The ability to generate and use reports from ePrescribing 
systems is the key to many second order benefits.
The most annoying and 
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Hospitals which started to implement ePrescribing as part of the Resource Management 
Initiative pilots in the late 1980s faced up to those fears many years ago. Nurses feared 
that “everything will take longer”, junior doctors worried that the need to plug into 
terminals on ward rounds would make them more remote from their patients.2  For 
hospital pharmacists, ePrescribing had the potential to substantially affect the way in 
which they practised, as it might reduce their presence on wards. They feared they 
would be stuck in the dispensary scrolling through screens, or spend their time entering 
orders for clinicians, as happens in the USA, and that clinical posts might be lost.3,4
A year later many of these initial concerns had dissipated5 and the hoped-for benefits 
had risen to the fore. Over a decade later, those same perceived benefits – legible, 
complete, accessible medication records; remote access to all clinical records; better 
formulary controls; and more and better clinical audit data – were found repeatedly in 
our interviews and survey data. 
In order to achieve these benefits, as a detailed evaluation of one pilot ePrescribing 
implementation6 makes clear, ePrescribing does affect the way people work because it 
reshapes routine tasks such as writing and screening a prescription, and doing a drug 
round, which become much more structured and rigid. The system forces the user to 
do things in a set order whereas with paper, steps can be skipped and returned to later. 
With ePrescribing, each step is made explicit but a degree of flexibility is lost. The art is to 
ensure that this is a strength and not a weakness.
The change in ways of working 
“The “rigidity” of the system highlights variation in practice.” [Senior doctor] 
Staff awareness of this change depends on their viewpoint, and also how much they 
reflect on the detail of a familiar routine activity. Senior doctors might think that the drug 
round was ‘still done in the normal way’ apart from the fact that a computer was now 
involved, while nurses in our interviews tended to see changes in terms of the benefits. 
They had a clear, complete list of medications due for individual patients, allowing them 
to focus on the patient rather than spend time looking for drug charts and medicines 
during the actual round. However, not all nurses saw a change in their work on the 
wards and some missed seeing the ‘full picture’ of the paper chart with up to two 
weeks’ worth of data on one sheet. The presentation of this data, so familiar from the 
drug chart/Kardex, varies significantly between systems.
 
Comments in our interviews and questionnaires point to significant changes in the way 
things are done, partly because ePrescribing makes preparing for tasks such as ward 
visits (pharmacists), ward rounds (junior doctors) and drug rounds (nurses) more efficient. 
Challenges and lessons learned PAGE 59
CHAPTER 7Managing ePrescribing in use
“Most junior nurses like the system, especially as it is almost paperless on the wards. We 
still have nurses who think it too ‘technical’ and are worried that they do not understand 
it. Many do not remember all the extra things they can gain from it – and they often lose 
their training information, or keep it at home! These are not all the older nurses either.” 
[Pharmacist] 
“Workflow is different as medication orders and history available allowing dispensing 
to be done immediately once an item has been clinically validated on the ward.” 
[Pharmacist] 
“We have computers on wheels, which can be moved to the bedside during consultant 
rounds, and prescribing can thus take place at the bedside, often done by a pharmacist 
and signed by a doctor…Dispensary workload is flattened – though not reduced – by 
ePrescribing. Not reliant on nurses going to tea etc. to bring down drug charts, or on 
pharmacists visiting wards to transcribe. Supply is more immediate – the orders arrive 
in the dispensary immediately -which means that great things are expected of our 
dispensary.” [Pharmacist] 
Pharmacists can check all the charts before they set out to visit their ward and then 
target patients with medication-related problems. Doctors can delegate part of the 
prescribing (order entry) process to pharmacists by getting them to key in the drug 
product and/or schedule administration times for doses. 
In the dispensary, some sites report that peaks and troughs in 
workload can be reduced (although these is some evidence the 
peaks just shift to a different time7) with less delay for clinical 
screening, and fewer phone calls or staff being sent down to ask if a 
patient’s drugs are ready. Nursing and junior doctors may notice that 
they see pharmacists on the ward less often that before, and some young staff who have 
only known ePrescribing may not know where the Pharmacy department is. Senior staff 
may sometimes use ePrescribing as a way of monitoring/auditing what staff do.
“You say ‘I have seen this patient’ when what you have actually done is prescribe for 
them.” [Junior doctor] 
In general, it is possible for a lot more things do be done remotely. 
This has implications for direct patient contact, particularly for 
pharmacists though also for junior doctors. Pharmacists may spend 
less time on the wards with ePrescribing and, like doctors, may be 
more likely to see many of their patients ‘through the data’ than in 
the flesh.6  While a doctor on nights may be more likely to prescribe 
promptly and accurately from their residency, pharmacists who screen from their desk in 
the pharmacy will miss being able to speak to patients and check the notes and IV lines, 
ePrescribing changes 
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reducing their patient safety function and, in some cases, stopping becoming part of the 
ward team.  Even when pharmacists still visit the wards it was sometimes reported that 
they spent much of their time there at the computer.
Changes in communication 
“What we used to have in my last hospital, which I liked …you used to know your ward 
pharmacist and they would have little post-its and if you wanted to discuss something...
you would ring them when it was convenient, whereas here it is quite a detached phone 
call.” [Junior doctor] 
When we asked pharmacists, nurses and doctors if ePrescribing has changed the 
way they communicate with others the response varied. In our survey, most thought 
communication had stayed the same, some thought it had increased, and a small 
number that it had decreased.
“More as we do a lot of hand holding in clinics and run the medics training.” 
[Pharmacist]
“Less - you don’t need to communicate or interact if you can message or propose 
but there is an audit trail. Interactions often don’t provide an audit trail to prove the 
interaction happened.” [Nurse]
 
Two people told us that ePrescribing had led to less interaction with other health 
professionals. At their trust, the fact that charts can be reviewed remotely, so staff did 
not need to come to the pharmacy, and that pharmacy staff could leave messages for 
doctors and nurses without needing to come to the ward, were seen as advantages 
because all these activities could be audited by the ePrescribing system. 
Other sites had differing perspectives, with some acknowledging the need to make sure 
that there were still appropriate opportunities for face-to-face interactions between 
healthcare professionals and staff – and patients. 
Security and PINs 
“I still have my PRHO mnemonic because I went on the system as that. So sometimes 
you get a phone call saying, I know you’re only a House Officer, what are you prescribing 
this for?” [Doctor] 
There are several security protocols for accessing ePrescribing. The one you choose 
needs to trade-off theoretical with practical security benefits. It also needs to trade-
off security with staff time spent on tasks, and their consequent (dis)satisfaction and 
motivation to create less secure workarounds.  Some hospitals had multi-level ID entry 
with a mnemonic login and a PIN they entered each time they actioned an order. Others 
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had just one login but with a short active time so staff could not wander off and leave a 
screen open for others to use.  
Who has responsibility for issuing ePrescribing passwords is also variable. In some sites, 
the Information Technology (IT) department had this role while in others, trainers, or 
‘super users’  issue logins, or a less formal system with ward sisters able to issue a “single 
shift” login. It is worth seeing if there is the opportunity for using the same sign-ins to 
other systems, so that for example the same code is used to access ePrescribing, PAS etc.
The frequency with which logins and PINs (personal identification numbers) were 
changed also varied, and procedures for cancelling logins for staff leaving the Trust  
were not clear. Frequent changes provided extra security - but also posed memory 
problems, with some staff writing PINs on their hands, or on the back of ID badges. 
Some prescribing ‘by proxy’ did occur when staff did not have (or had forgotten) their 
logins. If, for example, nurses have a 10 character PIN then it can slow down their 
working (particularly if it is decided PINS need to be entered frequently); this  
also encourages workarounds.  
Removal of authority is as important as creating it. One junior doctor, who had 
completed her pre-registration experience at an ePrescribing hospital then left, told us 
that she had come back to a more senior post and found that her old login still worked. 
Workarounds 
As staff get used to their ePrescribing system, some of them start to 
find ways to make it do what they want, such as bending the rules 
on who does what. Sometime these tricks are the only way to get the 
job done, however they may also be  safety time bombs. The good 
aspects of workarounds are that they can be a way of identifying 
how to do things better.  Workarounds can be a way of helping re-
configure the system (see next section) and make it more workable 
in day-to-day use.  The bad aspects are that often the workaround 
can be a very inventive way of by-passing a necessary safety feature.  
What is more, the people who develop them often have little knowledge about the 
system as a whole, and those with the system knowledge are unaware of the reality of 
daily practice.  Workarounds need to be known about and monitored to ensure they are 
safe.  We have identified the following examples of workarounds:
Barcoding bedside lockers rather than the patient 
If the ePrescribing system is linked to barcoded patient identification and the barcode 
ID on the patient wristband will not scan in, then medications cannot be accessed. So 
the nurse prints off another barcode label and sticks it on the patient’s bedside locker or 
table, with all the associated risks.
Workarounds can be a 
way of identifying how 
to do things better – 
but need to be known 
about and monitored to 
ensure they are safe
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Change the system clock or give first dose as a stat 
“One of the biggest training issues for us for doctors is training them that time does matter 
and if you schedule a weekly drug and it is due at 8 o’clock and you are writing it up at  
9 o’clock on the day it is due, then if you want today’s dose then you have to put 9 o’clock  
in because if you don’t it is not going to be due until next week.” [Pharmacist]
In ePrescribing, doses of a regular medicine need to be scheduled to a particular time 
window. If this is not done, the drug will not appear on the list of drugs due for a  
particular drug round and the nurses cannot administer it. Some doctors get round this 
by resetting the start time in the system. The other way to do it is to write up a stat (give 
now) order and put a note on the ePrescribing system to say that this is actually the first 
dose of a new regular medicine. These stat orders stay on the system longer, but with some 
ePrescribing systems if the patient has a long list of medications, they can fall off the bottom 
of the screen and be missed.
Delegated tasks (seniors to juniors, or doctors to nurses or pharmacists) 
On ward rounds, consultants have always delegated prescribing to junior staff.  
However, with ePrescribing those juniors may then delegate further, for example, by  
entering the drugs and then asking nurses or pharmacists to schedule the administration 
times. The ability to do this will depend on the ePrescribing system and local policy,  
and may not be possible with all types. 
Because consultants usually do less prescribing, they may be less familiar with ePrescribing 
and so find it quicker/easier to delegate to a junior on their team. Another practice is to have 
pharmacists on rounds inputting orders for consultants. 
“Simple drugs, given once or four times daily, work incredibly well. Giving stat drugs works 
less well and then variable dose things, Warfarin, can be a bit of a trial to prescribe and 
the same with anything fluid that is infusing. Seems to me to be beyond my capabilities to 
understand so I let somebody else do it.” [Consultant] 
Use of paper 
Non-formulary drugs or new drugs may not be in the ePrescribing drug dictionary so 
usually cannot be prescribed by junior doctors. But doctors can prescribe a medicine on a 
paper chart, regardless of its status. If paper charts are available (e.g. in case of unplanned 
downtime) then doctors may use them to get round a formulary restriction. 
Newly admitted inpatients – or those coming up to a ward as a day case – may need to be 
admitted onto the ePrescribing system before any prescribing can be done. This can prevent 
advance prescribing of medication. Using a paper chart can be one way round this. However 
this is also potentially risky procedure and, if paper is used is such circumstances, then extra 
checks will be needed and the prescription put on to ePrescribing as soon as possible.
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In-use configuration 
As user experience with ePrescribing grows, some groups start to learn how to configure 
systems to their needs. This is an essential step in improving the usability of the system; 
it needs to be carefully managed, but can significantly improve usability and safety. We 
identified the following examples: 
Dummy drugs: Flexible/variable dose medicines (warfarin, heparin, insulin, IV fluids) 
do not fit easily into ePrescribing and most hospitals still use paper charts to prescribe 
these. This could mean that items are not administered, or are missed off a discharge 
prescription. To help to minimise this risk, some hospitals have created ‘dummy drug’ 
entries in their data file, e.g. ‘on warfarin, see separate chart’ which can be prescribed  
on ePrescribing. 
Order sets: (e.g. post-operative regimens for individual surgeons/ syringe-pump 
formulations):  These sets, each containing several drugs, speed up prescribing,  
ensure a full regime of correctly prescribed drugs, and can make life easier for doctors.  
Provided you know what is in a set, it is easier to prescribe one and then delete  
elements you don’t want than to build it up from scratch. Some respondents were 
concerned that sets could be ordered without thinking whether the individual drugs 
were all safe for the patient concerned, for example, non-steroidal anti-inflammatory 
drugs in a patient with aspirin allergy. Some sites ensure that each drug has to be 
individually selected to mitigate this risk.  The risks need to be emphasised in training 
and monitored to identify problems. 
Formulary control: Non-formulary drugs may not normally be prescribable by 
junior doctors, but doctors can prescribe a medicine on a paper chart, regardless of 
its status. As noted earlier, if paper charts are available then doctors may use them to 
get round a formulary restriction – this may be a dangerous workaround and should 
probably be be discouraged. One approach is to make several, more sensitive, levels of 
access to drugs.  For example some sites are developing multi-level formulary control 
(not all ePrescribing systems support this), in which certain high-risk cytotoxic drugs are 
only available for ePrescribing prescribing by named people, and in which other drugs 
can only be prescribed by ePrescribing after discussion with an appropriate person  
eg: a microbiologist. 
Switching elements of decision support on or off:  Many people assume that 
the main patient safety benefit of ePrescribing comes from decision support.  This is 
rarely the case (although it may well be in a few years time).  Decision support can be 
powerful, but it is an area fraught with complexity, and it is unwise to attempt too  
much too quickly.  
A really good decision support system needs large amounts of resource behind it, and 
some have become so complex that they delay implementation of new prescribing 
policies, perhaps by months.  It is a huge task to maintain a system with rules relating to
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the BNF, NPSA, local PCTs, formulary and DT&C decisions, new drugs 
introduced to the market and new uses of existing drugs.  Unless 
resourced properly, this interconnecting web of knowledge and 
directions can easily become unstable, with conflicting rules for the 
same drugs.  For example, to change a first choice statin may take 
many weeks as people have to alter rules and ensure there are no conflicts.   
With decision support it is better to start simple and build up over time.
Decision support can be crudely divided into two distinct areas: decision constraint, 
which stops people doing daft things, and decision support, which guides and helps 
prescribing decisions.  
Decision constraint  can be very effective and is often implemented first. Configuring 
ePrescribing at this level is mostly decided early on before roll-out begins, and usually 
involves choosing those functions that will be used, and disabling others. Interaction 
warnings, for example, may be disabled if there is concern that  there are too many 
unhelpful ones or they are coming up at the wrong stage in the process. 
Setting of default doses, frequencies, routes and treatment lengths varies from hospital 
to hospital. The level of control also varies, depending on the situation, from ‘warning 
boxes’ (which can be bypassed if a reason is entered) to absolute blocks (e.g. making 
it impossible to prescribe oral methotrexate daily).  One of the hospitals with the most 
experience of ePrescribing only has warnings of the most dangerous drug interactions.
Where decision support is enabled, it is important to monitor it, for example the number 
of warnings produced and the number overridden, and to react to the findings.  
It is important that staff training emphasises the extent of decision support offered by 
the system. It has been found that some staff automatically assume an ePrescribing 
system will have decision support, so reduce their own vigilance when prescribing – for 
example not checking if the patient has an allergy to a drug because they assume that, 
on prescribing it, a warning will appear if an allergy exists.
A sophisticated decision support system would be expected to not only improve the 
safety of prescribing, but also the quality and cost-effectiveness.  If a hospital wants 
to achieve these benefits they need to adequately fund staff to run decision support.  
Assuming that existing staff will be able to absorb this workload is unrealistic. 
Interfacing with pathology test results: In a number of the sites studied the 
ePrescribing system was linked to laboratory results systems. This can provide a useful 
support for prescribing and administration activity, e.g. when warfarin is prescribed, the 
most  recent INR result can be displayed.
A really good decision 
support system is a 
huge task to maintain
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Discharge prescribing: The discharge prescription should be easily constructed from the 
inpatient prescription, however some ePrescribing systems may need to be configured 
specially to do this. There may also the opportunity to extend the interface further into 
the pharmacy. At one site, ePrescribing discharge orders interfaced directly with the 
dispensary labelling machine and could be linked with a robotic dispenser. 
ePrescribing and professional practice 
For pharmacists: ePrescribing probably has more sustained effects on pharmacy 
than any other profession, in that it changes supply and clinical monitoring functions.  
These changes will become greater over time.  Ultimately this could lead to the 
supply function predominantly being delivered by dispensing robots (already in use in 
many pharmacies), or being outsourced.  A negative impact has happened in some 
sites because of unrealistic expectations of hospital management, who assumed 
that ePrescribing would replace the pharmacist’s clinical role, and hence they cut the 
pharmacy establishment.  
The reality is that ePrescribing currently only replaces a small part of the clinical role.  
What is more, it takes a lot of pharmacists’ time to set up and maintain the ePrescribing 
system if it is to deliver the hoped for benefits to patient safety.  Hence pharmacy  
may need to have their staff increased, or re-structured, as ePrescribing implementation  
is undertaken.
Ultimately pharmacists, technicians and technology are interlinked in what need  
to be constantly evolving roles which increase patient safety and the quality of  
medicines use.
For doctors: It is important that senior medical staff are fully engaged, and that they 
influence their juniors.  Both seniors and juniors should have been involved in the 
planning and implementation of ePrescribing.  Time and priority needs to be given to 
training, and senior doctors should monitor and influence the performance of their 
junior staff. Junior doctors are sometimes too accepting of a system as it is, perhaps 
feeling that they will have moved on before their comments are responded to and the 
system is improved. However this just maintains problems for their peers.
Junior doctors (and pharmacist and nurse prescribers) should find some efficiency savings 
with ePrescribing, such as order sets, easy construction of TTAs, no need to rewrite drug 
charts, and the ability to prescribe from other places in the hospital (or sometimes other 
hospitals).  Speed of prescribing varies with the system and with experience, but we have 
seen computerised prescribing which was far faster than hand writing.
ePrescribing will provide information to prescribers, clinical directors and others, from 
which they can audit practices and compliance with policies far more rapidly and 
accurately than at present. 
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For nurses: In our interviews and survey, nurses tended to be the most cautious in 
their comments, while still generally positive. ePrescribing does have great advantages 
in terms of clear, complete, and available records but nurses feel they  need to shout 
more loudly about their particular needs for an ePrescribing system.  Having said that, 
ward sisters can make or break the success of ePrescribing roll-out, so they need to be 
heavily involved. To ensure nurses get the best from ePrescribing they should have good 
representation on implementation groups: should be involved in focus groups in early 
implementation and should be invited to contribute feedback.  Their presence should 
not only be on clinical groups but also on groups making decisions about space, choice 
of technology etc.
Drug rounds will be different with ePrescribing systems, although how different depends 
partly on the system in use and partly on local implementation decisions.  For example, 
some sites record a dose as given before taking it to the patient, however if the patient 
refuses it they need to be careful to alter the record; the alternative is to enter the drug 
as given once returning to the computer.  The way in which patients’ own drug schemes 
are used with ePrescribing can also be an issue.  It can be helpful for a pharmacist to 
accompany the first rounds to help identify problems, sometimes this can improve the 
pharmacy service to the ward; sometimes it just creates shared understanding of the 
constraints of the system.  The process of double sign-off of controlled drugs also needs 
to be agreed.
Nurses have a vital role, often going beyond their current role, in training and support, 
often undertaking the training for other professions.  
For ward sisters, managing small herds of COWs (WOWs) in an already crowded 
workspace could pose a problem (and a possible infection risk?). Some hospitals have 
used ordinary laptops but these are much easier to steal, so impose additional security 
that could be burdensome on a busy ward. 
ePrescribing future: Specific questions 
How do you foster and manage feedback and mutual learning? 
“Training is needed forever, IT support forever, a group will need to keep updating.” 
[Nurse] 
The message from the ePrescribing sites studied is that providing training and support 
needs more people and training than you think (one trust suggested budgeting for 
doubling initial manpower estimates) and is needed round the clock for as long as 
ePrescribing is in use. 
On-call support for the ePrescribing system, and managing planned and unplanned 
downtime, is also required. In some trusts, pharmacy has this role; in others, it is the  
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IT department. For training, the provider(s) chosen will depend on local circumstances  
and preferences, but it is essential to have clinical staff involved. Nurses (and in some 
trusts, pharmacists) are used as clinical trainers for doctors; pharmacists usually train their 
own staff. 
The aim of training is to get new staff up to speed with basic ePrescribing functions,  
so they can work effectively. The aim of support is to answer calls for help when the  
user cannot make the system do what he or she wants it to, or it goes down.  
Across the NHS there is a culture of not making a fuss and doing the best we can;  
staff grumble to their colleagues about specific issues but do not report them until they 
become critical. Our data suggest that current ePrescribing support services only pick 
up critical problems when users have been unable to get around these themselves. It is 
important that there is an active programme of identifying niggles and resolving them 
where possible.
“The most difficult part has been how reliably we can access the support, what their 
limitations are and how they escalate problems. Communication between the support 
team and the users is key – so the users feel able to ask for assistance before a difficulty 
becomes a problem.” [Pharmacist] 
However, as staff  become familiar with ePrescribing, they will start to develop 
workarounds and some groups will also start to reconfigure the system to meet their 
particular needs. These ad hoc developments tend to stay with the person or group 
that originated them, and most are only picked up by direct questioning or observation. 
It is important that there is a formal mechanism for monitoring these adaptive (or 
developmental) changes to the ePrescribing system and discussing them with staff. 
For example, this can be a role undertaken by trainers or support staff as they interact 
with their user community. It can be helpful to make it clear that such innovations are, 
in general, seen as positive, and perhaps to reward people for discussing them – for 
example with a ‘tip of the month’ competition. 
How do you deal with agency staff, assign passwords etc? 
Agency staff will probably not be trained on ePrescribing, or have authorisation to use 
the system. This means that agency nurses cannot give drugs, making them expensive 
for what they can do. Many of the ePrescribing hospitals we spoke to only used them  
if there was no other alternative. Instead they set up their own “bank” of trained  
part-timers, or made existing staff cover. For medical and pharmacy staff, the strategy 
was to use “regulars”. This is feasible in trusts where staff turnover is low and people 
tend to stay living in the hospital area but poses a larger problem for hospitals with 
a rapidly changing staff base. A related issue is the issuing and maintaining security 
of passwords/logins/PINs for ePrescribing, which will be a much larger task in a large 
hospital with high staff turnover, particularly if it is in an area where on-site IT-related 
thefts and other crime are problems. 
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 What else can you do differently once drug use data are online? 
“ePrescribing allows us to produce detailed prescribing reports on clinical areas and 
down to individual consultants. Using antibiotic prescribing as an example, this has had 
a dramatic effect on the use of drugs known to increase the risk of C difficile and MRSA 
infections. There is an added bonus of now being able to identify prescribing costs by 
clinical areas.” [Consultant] 
“Senior nurses can do complaints, investigations, monitor infections, see if patients are 
in beds, see how many beds are in use, which patients are on which areas, who is on 
duty.” [Nurse] 
Participants in our survey thought mainly about getting data into the system, and the 
task at hand in the immediate context of use. They did not think about getting data out.  
It may be assumed that, because the data is in the ePrescribing system, that it can be 
easily extracted and analysed in any way you want. This may not be true.  
People tend to think about reporting or possibilities for analysing aspects of their practice 
rather late in the day.  Most nurses we interviewed did not immediately see a need to 
have reports but could, if pressed, imagine useful audit data on the drug administration 
process. For example, they saw ePrescribing data as a way of monitoring and confirming 
what individuals had (or had not) done. Pharmacists could see uses for data in clinical 
prescribing audits, but not as a tool to look at their own activities. In some sites, 
ePrescribing does in theory allow pharmacists to audit their interventions but this data 
does not seem to be generated, or examined, routinely. 
Those who did want to extract, relate and interpret data – e.g. for clinical audit, 
research, management or to support other process changes - were often frustrated, for 
several reasons:
•	 in some cases the data structure of the system would not allow it. 
•	 in some cases because writing a report needed specialist technical knowledge or 
access to a particular person. 
•	 sometimes because the supplier company  wanted too much money to do the 
necessary work within a reasonable time frame.
•	 sometimes because a technical group used their ability to generate reports as a way 
to retain control of the system. 
From the information we gained it appears that at present, reports mostly have to be 
specifically ordered, or a template for one requested. Sometimes a member of the 
pharmacy staff has the necessary expertise to do this; sometimes a request is handled 
by a completely separate department. Either way, the need for the report has to be 
clear, and the person requesting the data has to be fairly senior.  Staff are not usually 
encouraged to learn how to get relevant data out themselves. While this protects the 
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privacy and ssecurity of personal information as well as system performance, it also 
reduces the likelihood of solving problems and identifying useful information such 
as important trends. The wider exploitation of the data stream and how to manage 
this (within appropriate privacy and security concerns) should be an initial part of any 
ePrescribing project’s goals. 
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The technologies of  
ePrescribing
Introduction
By definition ePrescribing makes use of information and communications technologies. 
Most contemporary implementations use hand-held or mobile devices and wireless 
networks, as well as fixed workstations and wired networks. Similarly, almost all systems 
rely on standard packaged software to provide the basic functions of prescribing, 
administration and recording medicines use, and almost all make use of standard drug 
dictionaries and databases to allow these systems to offer decision support to prescribers.
Feedback from experiences of those who have implemented ePrescribing systems 
suggests that most of these technological elements have potential problems or issues 
associated with them. It is seldom wise to assume that technology will work the way it is 
presented. In other words, ‘what it says on the can’ may not be your best guide to what 
actually happens. 
Our interviews with people who have worked to make ePrescribing systems work in 
real hospital settings often reveal that the frailty of technology only becomes clear as 
implementation proceeds, and the bland assurances of technical and IT staff that it is all 
OK and will work can come unstuck. 
It is not the purpose of this report to offer detailed guidance on the choice of hardware, 
networks or software packages, but rather to report lessons learned. The chapter is 
organised as a catalogue of various technological elements of ePrescribing systems 
Key messages 
•	 ePrescribing is reliant on a number of technologies; each has its own role, but also its own 
potential problems.
•	 Software may be bought as a ‘package’, but it may need extensive work to install it in any 
particular hospital setting.
•	 Developing a good relationship with the suppliers of software and hardware is important. 
•	 Mobile devices are helpful to take ePrescribing to the care setting. However their choice needs to 
be carefully considered. 
•	 Experience among NHS hospitals suggests that wireless networks are often the weak link in 
ePrescribing implementations.
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broadly divided into three sections: software, hardware and networking, and paper.   
We provide a brief description and some account of how each of these technologies 
have proved useful, but also problematic.  We hope that for those who have to manage 
future ePrescribing projects forewarned will be forearmed. 
Packaged software 
In almost all cases, electronic prescribing implementations are based upon packaged 
software provided by specialist developers. The market for ePrescribing software can be 
roughly divided between three (or four) major types.
Developments of pharmacy based systems (e.g. JAC, Ascribe). At present the majority 
of implementations of ePrescribing in England are based around extensions of existing 
pharmacy software packages. This is understandable if you see ePrescribing as an extension 
of such systems, and as sharing many common parts.  For example, a database of drugs, 
pack types and sizes and as undertaking essentially similar tasks such as stock control. 
Clinical specialty based (intensive care unit - ICU, oncology). Some areas of medicine 
have distinctive needs for ePrescribing because of the style of care they offer, or the 
complexity of the medicines regime they employ. ICU and chemotherapy are two 
areas in which there is great interest in ePrescribing and fairly wide spread adoption of 
systems. Another specialist area is prescribing Parenteral Nutrition (PN). There are a small 
number of software products from suppliers that are targeted at these specialities. 
Components or modules of larger hospital information system packages (Cerner 
Millennium, iSoft Lorenzo, Meditech). At present neither of the principal packages that 
are used within the National Programme for Information Technology has an ePrescribing 
module in use. However, ePrescribing figures as one of the modules that will be available 
in phase 2 of the roll-out plans of both iSoft Lorenzo and Cerner Millennium. The 
Meditech package is in use in a number of UK hospitals, and supports ePrescribing. For 
example, Queens Hospital, Burton upon Trent, has used Meditech ePrescribing for over 
10 years, and Sunderland has implemented it hospital-wide in the past few years.
Home grown software. In the past the pioneers of ePrescribing had to develop 
their own software because none existed. For example, a few hospitals have built 
and implemented their own systems across the hospital, notably University Hospital 
Birmingham, but few we suspect would embark on this route today. The exception 
might be for limited functionality systems that implement some partial elements of 
ePrescribing, in particular discharge prescription/TTO systems. This is a limited area 
in which a hospital or trust may see it as appropriate to develop their own software, 
though they should understand the risk this poses of building a system that cannot 
integrate with and develop alongside other parts of the hospitals’ information systems. 
There are also issues of the legal basis of prescribing and managing medicines orders 
that need to be addressed. 
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Whatever software is used, it is important to fully understand the scope of the system 
and manage how this relates to local needs and expectations.  There are certain 
common issues that need to be considered. Here, based on our study of ePrescribing 
implementation experiences, we consider four: customization, installation, configuration 
and templates. Each of these are important activities in setting up ePrescribing software, 
and each needs to be resourced with an appropriate management structure and 
appropriate skills.
Customization, installation, configuration and templates; 
Packaged software cannot be put to work straight off the distribution 
disk or in a matter of a few days. It will always need to be ‘set up’ 
before it can be used. This is a complex and time consuming activity 
that needs to be resourced.
Customization: Customisation occurs when we get the code adapted because of our 
special needs or requirements. In general customization is a bad thing. It may be possible 
to persuade a software supplier to do such work (at a price), but this is almost always 
stocking up trouble for the future. For example, a customized version of a standard 
product will probably require re-customization (at a price) if and when the standard 
version is updated and released as version n+1. Customization may also 
introduce new errors into the code, errors that may not be detected 
until too late. Local customization should not be confused with local 
configuration (below).
Installation: Software for ePrescribing will need to run on a number of different 
computers. There will be servers to hold the shared data on medicines orders, stocks, 
drug names etc, as well as laptops or workstations around the hospital to be used 
to input and check data. Each of these machines need some software loaded on to 
them and this software will need to be periodically updated. ePrescribing systems will 
also need to be interfaced to other systems, for example to obtain patient numbers 
and demographic data from the PAS, to integrate with an existing EPR, or to validate 
individual logons by staff and enable relevant prescribing privileges.
Managing and maintaining the installation in an efficient and safe way takes time and 
the specific skills of IT professionals. Some software makes this easier than others. For 
example some ePrescribing packages can run in a ‘fat client’ or ‘thin client’ mode. In the 
latter, the main programs are maintained on a limited number of servers, and the clients 
(laptops, tablets, workstations) use a web browser or similar software to access them. 
The result is to make it far easier to manage and update the software over time.
Configuration: If customization is a bad thing, installation a necessary thing, then 
configuration is good thing. Packages for ePrescribing are (certainly should be) designed 
to allow system sponsors to make many specific decisions as to how, in their own 
context, the software will behave. 
Packaged software  
set-up is complex and 
time-consuming and 
needs to be resourced
Customization is almost 
always stocking up 
trouble for the future
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For example, what degree of decision support will be offered to prescribers, how will 
antibiotic durations be set (or not), when will alerts trigger, how large a time window is 
allowed for an ‘on-time’ administration of a medicine. These questions constitute a very 
long list, and each one will need to be thought about and answered. One of the most 
substantial parts of any implementation of ePrescribing will be to work through these 
questions, establish the appropriate answer for the situation, configure the software 
appropriately, and then test it. In many cases current practice may be clear, consistent 
and appropriate, but in many areas they will be none of these, and it will take time to 
work out the appropriate configuration.
 
It is worth investing some time to learn about all the configuration 
options before making any decisions.  Once made, decisions should 
not be set in stone; system sponsors must be prepared to review and 
alter configurations in light of experiences during initial set up and 
ongoing use.
Templates: Templates are standard descriptions of how a certain set of data is managed, 
collected or displayed. Templates may be seen as a special case of configuration, but 
deserve their own consideration because they are one of the most powerful ways of 
obtaining the benefits of ePrescribing. Examples of a template might be the content of 
a discharge summary, the definition of order sets, or the allergy entry screens. Each of 
these cases could be seen as a detail of configuration, but while many configuration 
decisions are made once early on in an implementation, these types of decision are able 
to be adjusted over time, extended and reworked. 
Migration and versions
As alluded to above, software systems are almost always delivered over time in different 
releases - version 1, version 2 etc, and perhaps with minor revisions in between as 
version 1.1, version 1.2 etc. Almost all computer users are familiar with this characteristic 
from their experience of Windows (2000, XP, Vista). Shifting up as new versions are 
released may be wholly desirable if the new version is better, faster, safer... but it 
may equally be a problem if the new version requires substantial re-working of work 
practices, technical infrastructures etc. 
 
Experience suggests that moving between versions can cause difficult periods,  when 
problems become apparent. Upgrades to software that should be simple, transparent to 
users and wholly desirable, can become nightmares of lost data, poor performance and 
compromised safety. New versions should always be tested before implementation in the 
live environment.
The question of choosing a version also arises for initial implementations. For example, 
given the choice of an initial implementation of the old, tried and tested version 3 of an 
ePrescribing system with three years use in other similar hospitals, or the new, enhanced 
(but un-tested and un-tried) version 4, which should you go for?
Invest time to learn 
about all configuration 
options before making 
any decisions
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Relationships with suppliers, 
The suppliers of software we must assume want it to work for you, 
and should therefore be prepared to put in a substantial effort to 
help their customers get the best out of their software. For example, 
people interviewed during the study appreciated suppliers who could 
supply training materials (probably for local configuration), speedy 
technical support, on-site support during go-live and help to make 
contacts with previous sites that use their software. 
Suppliers also need to be ready to hear about what is not working well, of features  
and functions that the software does not support but should. While we have suggested 
the customization is not a good practice on a site-by-site basis, it certainly is the case  
that the supplier should be actively canvassing ideas to be fed into the next release that 
they develop. This may be a cycle that takes two or three years to complete from request 
to possibly a new function being delivered, but it is central to the thriving of  
any software product.
Drug dictionaries and databases
All ePrescribing systems involve the selection of a drug from a ‘pick-
list’.  These ‘pick-lists’ or drug dictionaries may be built locally but 
more commonly come from a commercially available (third party) 
supplier of drug information.  It is advisable to use a drug dictionary 
that is compatible with dm+d (a dictionary containing unique 
identifiers and associated textual descriptions for medicines and medical devices), as this 
is anticipated to become the NHS standard for medicines and device identification.
Any ePrescribing system that goes beyond simple data entry also needs a database 
of drugs and their properties. Drug databases in use or under development in the 
UK to support secondary care currently include the British National Formulary (BNF), 
the Multilex Drug Data File from First DataBank Europe (FDBE) and Multum’s Drug 
Information.  These databases receive regular monthly updates and the time to do this 
for a live real-time ePrescribing system needs to be planned carefully.  Similarly, release 
alterations also need to be tested for, especially if they are substantial.
Hardware and networking 
As well as ePrescribing software, specific computer hardware and networking are also 
essential parts of ePrescribing. A detailed specification is beyond the scope of this report, 
and in any case varies with the particular situation and the computers, workstations and 
networks that are already in place. Below we summarise the key elements of hardware 
that are needed.  This is followed by some detailed descriptions and a discussion 
presenting some of the issues faced by ePrescribing implementers.
Suppliers should help 
customers get the best 
out of their software – 
and be ready to hear 
about what is not 
working well
Use a drug dictionary 
that is compatible  
with dm+d
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The key elements of technology required as minimum when ePrescribing is planned  
are as follows: 
•	 Server computers: to run the ePrescribing software, store prescriptions data, hold the 
necessary databases that underpin ePrescribing and as backup.
•	 Desk-based computers (sometimes called ‘workstations’): these are needed in 
all wards, pharmacy departments and other areas where prescribing, administration or 
review of medication takes place - including potentially off-site. For some tasks only a 
desk based machine will do. 
•	 Mobile devices: most implementations of ePrescribing use mobile devices of some sort 
to allow tasks to be completed at the patient’s bedside. These may include workstations 
on wheels (WOWs), laptop computers, pen tablets or personal digital assistants (PDAs). 
Increasingly, specially developed Mobile Clinical Assistant (MCA) devices are being used in 
a range of clinical systems including electronic prescribing. 
•	 Networks: in order to link devices and allow sharing of data a secure and reliable 
network infrastructure is needed. Where mobile devices are used, a secure and reliable 
wireless network is essential. 
•	 Interfaces to other systems: among the other computer-based information systems 
that may be interfaced with ePrescribing to send data one way or the other are patient 
administration systems (PAS), pathology laboratory systems, bed management systems, 
electronic medical records and pharmacy stock control systems. 
•	 Back-up systems and devices: when any part 
of this technical infrastructure stops working, as 
it will inevitably do one day, there needs to be an 
appropriate backup device, or a backup procedure. 
Thus it is common to have duplicate ‘shadow’ 
servers which can be quickly brought into use if 
one of the main servers fails. Another common 
practice is to have separate computers and printers 
on standby holding a recent (perhaps up to 30 
minutes old) backup of the patient prescription 
data. These machines can print out paper charts if 
it is anticipated that the ePrescribing system is going 
to be unavailable for any length of time. 
Ward based work-stations or mobile devices?
Depending on the clinical setting, ePrescribing systems 
need to use some appropriate computers in the direct 
settings in which care is delivered. On a ward, this will 
usually mean at the bedside for prescribing as well 
as administration and recording. In outpatients this 
may mean standard desk based workstations, while 
other settings such as A&E or ICU will pose their own 
problems and require their own choices be made as to 
the appropriate devices to use.
Working at the bedside reading a barcode
Computers at the nurses’ station
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Once we move away from the desktop work station, which devices to choose is  
not straightforward. Consider the possibilities: WOWs, laptops, PDAs, tablet PCs  
or MCAs? 
Most people agree that a truly portable, pocketable device such as a PDA has too 
small a screen to be able to safely display enough information for most ePrescribing 
situations, plus the screens may not be ‘sharable’ if two or more people are engaged 
in the same task. Laptops, taken alone, are unwieldy to use in a ward situation.  
Where do you put them down when you move to some other task? There are now 
available specialist tablet devices such as the MCA which attempt to address some 
of these problems by allowing for suitable handles and hooks, as well as cleanable 
keyboards, powerful batteries and a bright screen. Some versions also come with 
extras such as a bar code reader built in. 
However, in most ward situations, ‘mobile’ means ‘on wheels’. And so computers 
are fixed to a trolley, perhaps the notes trolley or the drug trolley, as a compromise 
solution. But the ergonomics can easily be very wrong if the trolley is inappropriate in 
design. Using a keyboard and a mouse or pointing device, as well a viewing a screen, 
is not best done when bending over. For this reason the choice made is often to use 
purpose-built WOW stands to hold a computer with the screen, keyboard etc. These 
can be height adjustable so that an adult standing up can comfortably use them. 
WOWs, however, pose their own problems. As mobile battery powered devices, 
WOWs need to be regularly recharged. The ability of a standard lap top to hold a 
charge may be frustratingly just short of what is needed for a full day on a ward. 
One solution that is sometimes used is to have larger more powerful batteries on 
these trolleys, but in that case they become heavier to move and more bulky. The 
most significant issue when used in a ward setting is perhaps the extra clutter they 
represent. Most wards have enough equipment on wheels already, and it is not easy 
to find room for four more in the corridor, as well as access to sockets to recharge 
their batteries. These devices also need to be regularly cleaned, and therefore 
designed to be cleanable.
Working on a tablet pc Sharing a laptop
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Another important consideration is the number of computers.  How many 
desk-based workstations and how many mobile devices?  Too many may 
have financial, storage and maintenance implications, but too few may have 
a negative effect on the users willingness and acceptance of ePrescribing as 
a whole.   What happens when the only MCA or WOW on the ward breaks 
down?  It is a good idea to let nurses and other clinical users trial different 
styles and numbers of mobile devices to decide what best suits their needs 
before ordering large quantities.  Space is often a determining factor, and 
the most obvious choice of device in theory may not work out in practice.  
Likewise, wards or clinics may overestimate the number of devices they need.
Remote work-stations (off ward/off site) 
One of the positive aspects of ePrescribing that is often reported is the  
ability to access prescribing/medicines functions away from the ward setting.  
A pharmacist can, perhaps, screen patients before a ward visit while still in  
the pharmacy, or a doctor on call at night can enter/authorize a prescription 
from another ward or the mess.
Bar codes, bar code readers, bar code printers 
Some ePrescribing systems that are in use today make use of barcodes as a 
means for data entry. For example, if patients have barcodes on their wrist 
bands, then positive identification is possible at the time of administration. 
Although this is eminently sensible thing to do, and may help to prevent 
some errors occurring, bar coded wrist bands are not as yet very commonly 
integrated with ePrescribing. 
Experience of those who have used them is that, in general, they work. The 
straps themselves survive life on a ward, and the printers and readers that are 
necessary work too. However, as in most other areas, if such devices are an 
essential part of an ePrescribing system in use, then there should be backups or 
spares available all the time.
ePrescribing system operating in the pharmacy Using an MCA
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Radio Frequency Identification (RFID) 
In the future a RFID tag may play the same role, allowing a patient to be identified by 
just passing a wand close to them. However, as yet, we are not aware of any RFID usage 
in live ePrescribing systems, though they are being piloted for patient identification, 
and are used to track blood products. See http://www.connectingforhealth.nhs.uk/
systemsandservices/bloodpilot/gs1aidc.
Wireless networks 
One technology that we want to focus on is wireless networks 
(WiFi). As noted above, almost all whole hospital ePrescribing 
implementations make use of WiFi to allow mobile devices to be 
used. The issues of security and safety that such networks raise have 
generally been solved, and they are in widespread use in hospitals. 
However, from the sites studied we have found a very common 
concern with the performance of such networks. In almost all sites that use WiFi the 
ePrescribing system has gone live only for the hospital to discover that the wireless 
network is incomplete, has black spots or is liable to crash. 
Two linked problems seem to occur. First, good experience with wired networking may 
lull people into a false sense of security about the ability of a wireless network to take 
on more traffic. Wireless networks degrade far more rapidly than wired ones as more 
devices and more data seek to share their capacity. 
The second common problem is that the coverage of WiFi is inadequate, and certain 
places, perhaps some bed bays on a ward, are not able to locate or maintain a signal. 
These types of problem can be very disruptive of a successful move to ePrescribing. 
Indeed  one hospital had to take much of its ePrescribing out of use for a period of 
months while the network inadequacies were identified and fixed. In another, it took a 
frustratingly long period of time before the IT managers and the responsible contractors 
agreed that indeed there was a problem. Meanwhile,  a debilitating general feeling of 
frustration built up among the users.
Paper 
The last technology that we want to consider is paper. ePrescribing systems are  
about using less paper, in particular not using a drug chart, but they are not  
about using no paper at all. Indeed, paper plays a very important role in most 
ePrescribing implementations. 
Problems with WiFi 
performance and 
coverage can be very 
disruptive
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Four main roles for paper might be found:
The first is as part of the backup system. If and when an ePrescribing system fails, 
then paper will be needed to continue to manage medicines. This may be paper that is 
printed off by dedicated computers from a backup of the live system. There also needs 
to be paper available to undertake administration, keep records etc if any part of the 
system fails. In some sites wards have an emergency box with set of pre-printed forms 
for use if and when needed.
The second use of paper is as an adjunct to the computerised system. For example, 
most current ePrescribing implementations cannot support the prescribing of warfarin. 
This requires a paper form to allow for the prescribing of a daily variable dose based on 
the blood results/INR (international normalised ratio) value. A reference to the paper can 
be made in the computer, which allows safe prescribing to be undertaken. Another area 
where printed paper might be an adjunct to ePrescribing would be when a patient is 
taken to theatre, and a print out of current medications accompanies them.
The third use of paper is as a short term memory support. In some ePrescribing 
implementations, for example, a nurse can ‘print off’ a patient’s medications record as a 
reminder to undertake some task – perhaps to ensure re-supply of some medicine. Using 
paper in this way may be controversial in that it seems to undermine the purpose of 
ePrescribing to banish paper. 
The final use of paper is as a means of reporting results from ePrescribing. For 
example, in many situations, medicines records may need to be printed off to 
be included in a patient’s paper file, at least until a full EHR is working alongside 
ePrescribing. Similarly, all manner of summary and management reporting from 
ePrescribing will be required on a daily, weekly, monthly and ad hoc basis, and for this 
usually paper will be the desired final output medium.
Reducing reliance on paper is a valid objective for ePrescribing 
implementations, but its elimination is probably not. Paper remains a 
very flexible medium to share information, a useful way to transmit 
data, and a vital means of providing backup.
Reducing reliance 
on paper is a valid 
objective; its elimination 
is probably not
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The vision for 
ePrescribing needs  
to consider longer  
term aims
Looking forward - integrating 
ePrescribing into infrastructure 
and practice 
Introduction
We conclude this report by considering the bigger picture of ePrescribing and its potential 
as part of the hospital infrastructure, once it has been established for several years.  
There needs to be a vision for where the ePrescribing system fits into 
the healthcare organisation as a whole. Medicines are the commonest 
form of treatment and the most expensive part of healthcare after 
staff costs, which makes their management of more than passing 
interest. Hospitals with ePrescribing systems also need to appreciate 
that commitment to any given system can have long term negative 
consequences, for example if you become locked in to a particular supplier,  
particular hardware, or particular data standards. 
Key messages 
•	 Medicines are the commonest form of treatment, and the most expensive part of healthcare 
after staff costs. ePrescribing can provide comprehensive information about the uses and costs 
of medicines, and can control and influence the use of medicines. Hence ePrescribing is essential 
for any provider organisation to thrive in healthcare. 
•	 ePrescribing systems of the future can, potentially, be developed to offer a more integrated 
medicines supply chain and more real-time monitoring. 
•	 They can equally be developed to provide benefits in a number of areas; to offer more 
information to patients, for research purposes, for practice review and development, for 
education and for professional development.
•	 ePrescribing systems are not, primarily, about increasing efficiency of individual tasks, though 
they may be able to offer such benefits in time, but they can serve to support the efficient 
management of medicines and contribute to efficiencies of scale as they become integrated 
with other systems. 
•	 To the extent that ePrescribing can reduce ADEs and support safety improvements they can 
potentially generate cost savings.
•	 Commitment to any given system can have long term negative consequences, for example if you 
become locked in to a particular supplier, particular hardware, or particular data standards.
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The vision for ePrescribing in strategic terms needs to go beyond the current software 
and hardware, and the current uses, and consider longer term aims.  For example, 
the original vision of the National Programme for IT was improve the quality and 
convenience of care by ensuring that those who give and receive care have the right 
information, at the right time, and to use information technology to directly improve the 
patient experience and clinical care.  The creation of Foundation Trusts and existence of 
a competitive provider market place means that ePrescribing systems are now more likely 
to be addressed as part of a process of strategic planning for information systems, and 
to be evaluated as part of the development of an integrated set of systems.
Taking this wider view, ePrescribing systems can be considered in relation to three key 
dimensions; safety, quality and efficiency. In the next section we spell out some of the 
visions for the future of ePrescribing in these terms.
Safety and quality
Safety and quality can be seen as a continuum and so we bring them together here.   
We not only want to reduce the number of errors in prescribing, dispensing, 
administering, monitoring and transferring information about medicines, we also  
want to improve the quality of these processes. 
The integration of information systems will be important in achieving this, and must 
be seen as an important goal.  Within the hospital, links to the patient administration 
and care records systems are important, and to pathology results and ultimately to 
the Summary Care Record, to support the transmission of information to the GP and 
community pharmacy.
Thought also needs to be given to linking ePrescribing to other technologies, for 
example once there is integration with pharmacy dispensing systems, there can be links 
to robotic dispensers, which could be in the pharmacy, on the ward, or in accident 
and emergency. There could also be links to ‘intelligent’ IV pumps and cytotoxic 
reconstitution machines. The dose provided by an IV pump could be adjusted according 
to feedback from sensors that measure parameters such as pulse, blood pressure, blood 
oxygenation etc; indeed, drugs could be prescribed or stopped from such algorithms.  
While such systems may sound very futuristic now, even dangerous, there is a great 
deal of development work going on in these areas. Thinking through the possibilities 
for ePrescribing systems to migrate into such areas can be an important contribution to 
assessing the desirability of such a future.
In addition to making systems safer through accurate capture, storage and transfer  
of information, more can be done by using and relating the information in the system  
in different ways.
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•	 Identification of any new error types that occur with ePrescribing, together with  
appropriate remedial action.
•	 Ongoing monitoring of certain error types, for example by conducting regular 
‘programmed’ missed dose audits and audits of prescribing errors identified by 
pharmacists. Incident report data cannot be used to assess error rates, but can be 
useful in identifying new types of error that are reported. 
•	 New drugs can be monitored to see how they are prescribed in practice and, if 
related to other data, can be monitored for new side effects, and also for the real 
costs of use.  There is great potential for a national database relating this information 
in large pharmacoepidemiological and pharmacoeconomic studies.
•	 Professional staff can become more involved in improving the safety of their 
practices.  Provided the databases are set up appropriately, it should be relatively 
easy for professionals to test the accuracy and quality of their actions (prescribing, 
monitoring etc). For example, an ePrescribing system could be used to identify any 
patients who have not been prescribed an ACE inhibitor, statin and aspirin following 
a myocardial infarction, or any surgical patients who have not been prescribed a 
heparin as thromboprophylaxis.  It will also be easier to evaluate new practices for 
their safety.
•	 ePrescribing system records can be the basis of training databases for all professions, 
both as students and as continuing development and specialisation. The ability to 
review and follow the medicines use process in a large sample of patients could offer 
the opportunity to improve doctors knowledge of prescribing.
•	 There may also be potential for patients to use ePrescribing systems to access 
information on their medication, for example by providing information sheets at the 
time of discharge, or as follow up.
 
Efficiency
Staff may well find that working with an ePrescribing system takes longer initially. 
However, in time increases in efficiency should become more apparent, certainly if 
the whole task cycle is considered. Extra time on one task will often be outweighed 
elsewhere on the medicines use process. Such efficiencies are more likely to be realised 
with systems that are integrated into other hospital systems (pharmacy computer system, 
patient administration system, etc).  There are also economies of learning if systems have 
common features.  
If safety improvements reduce adverse events, potentially substantial 
cost savings can be made.  An important part of managing and 
developing ePrescribing systems is to carefully collect and analyse 
data that might support such claims. ePrescribing systems also make 
it possible to accurately charge for drugs, for example in the case of 
private patients.
If safety improvements 
reduce adverse events, 
potentially substantial 
cost savings can be 
made
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Conclusions
ePrescribing systems require an ongoing governance strategy.  ePrescribing systems need 
to be constantly monitored and developed for themselves, but they equally need to be 
managed within the evolving context of broader developments of information systems 
in and beyond the secondary care setting. Implementation of ePrescribing needs to be 
about medicines management innovation first, the evolving broader environment of 
clinical data second, and the technical details last. 
Medicines, as noted above, are the commonest form of treatment, and the most 
expensive part of healthcare after staff costs.  ePrescribing can provide comprehensive 
information about the uses and costs of medicines, and can control and influence 
the use of medicines.  For these reasons ePrescribing is essential for any provider 
organisation to thrive in healthcare. 
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Objectives
Original specification from NHS Connecting for Health
The original aim, objectives and outputs from the NHS Connecting for Health work 
package specification were as follows:
Aim
The ePrescribing programme would like to commission a piece of work that identifies 
the lessons learnt and how users and culture developed and changed with the 
implementation of ePrescribing. 
The work should focus on sites that have implemented ePrescribing within the NHS (this 
may include successful implementations as well as those that have failed providing there 
is insight that can be utilised). Lessons learnt in arenas other than the NHS should also be 
reviewed and relevant lessons incorporated. 
Objectives
There should be particular emphasis identifying and outlining the following objectives:
•	 Processes undertaken to manage implementation and the scope of the 
implementation (e.g. whole hospital, specialist clinical, specific process etc).
•	 How system rollout was managed – the challenges and lessons learnt.
•	 How behaviour changed and the challenges associated with this.
•	 How the users and the culture developed and changed.
•	 Lessons learnt that should be shared and which mistakes to avoid.
•	 Identifying resources that might be shared.
•	 Identifying what has not been possible, why and whether these remain aspirations. 
•	 Describing how systems have been used to support the development of practice.
•	 Identifying benefits that have been realised as result of ePrescribing deployment.
Outputs
The work will form the basis of a toolkit that can be used in a variety of settings to 
support education and training for the implementation of ePrescribing. Outputs should 
be produced with this in mind.
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The main output will be a detailed report outlining all of the information obtained. There 
should also be shorter documents produced that highlight the main learning points that 
can be used as an educational tool for clinical staff and managerial staff. The number 
and type of these should be determined according to the information obtained and 
different types of focus that have been highlighted. 
Coupled with the written reports there should also be summary PowerPoint 
presentation(s) produced that can be used to support local implementation activities. 
These may be supplemented by workshop material if this is felt to be appropriate.
All outputs must be written in a manner that invites reading by front line staff – detailed 
technical and results driven output is not acceptable. The steering group would expect to 
review, comment and sign off copy before it is produced in final format.
Study objectives
The objectives of our study were as follows: 
•	 To accumulate and summarise the varied experiences of NHS hospitals as they have 
implemented various versions and styles of ePrescribing. 
•	 To review the relevant international literature on the implementation of ePrescribing, 
commenting on the messages that can, and cannot, be extrapolated to the UK. 
•	 To develop a set of short and informative practitioner-facing briefs that address key 
aspect of ePrescribing. 
•	 To prepare a summary PowerPoint presentation on Implementing ePrescribing. 
To validate these outputs by the review of the draft work by a selected international 
panel of experts. 
APPENDIX 1Objectives 
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Benefits of ePrescribing 
The web site of NHS Connecting for Health contains the following accounts of 
ePrescribing, http://www.connectingforhealth.nhs.uk/eprescribing/benefits 
Over time ePrescribing systems will provide for: 
•	 Computerised entry and management of prescriptions. 
•	 Knowledge support, with immediate access to medicines information, e.g. BNF. 
•	 Decision support, aiding the choice of medicines and other therapies, with alerts such 
as drug interactions. 
•	 Computerised links between hospital wards/departments and pharmacies. 
•	 Ultimately, links to other elements of patients’ individual care records. 
•	 Improvements in existing work processes. 
•	 A robust audit trail for the entire medicines use process. 
If ePrescribing systems are developed and implemented effectively, they have the 
potential to deliver a wide range of benefits, including: 
A reduction in the risk of medication errors as a result of several factors, including: 
•	 More legible prescriptions. 
•	 Alerts for contra-indications, allergic reactions and drug interactions. 
•	 Guidance for inexperienced prescribers. 
Process improvements as a result of: 
•	 Improved communication between different departments and care settings. 
•	 Reduction in paperwork-related problems, e.g. fewer lost or illegible prescriptions. 
•	 Clearer, and more complete, audit trails of medication administration. 
•	 Improved formulary guidance and management and appropriate reminders within 
care pathways. 
•	 Computerised links to hospital pharmacies, facilitating quicker supply. 
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Abbreviations
A&E  Accident and Emergency
ADE  Adverse Drug Event
CDS   Clinical Decision Support
COW  Computer on Wheels (see WOW)
CPOE   Computerised Provider Order Entry
CRS  Care Records Service
EHR  Electronic Health Record  
eMAR  Electronic Medication Administration Records
ePrescribing   Electronic Prescribing
EPICAL  Electronic Prescribing Implementation: Challenges and Lessons
EPMA  Electronic Prescribing and Medicines Administration
EMR  Electronic Medical Record
EPS  Electronic Prescription Service
FAQ  Frequently Asked Questions
HCP  Healthcare Professional
IM&T  Information Management and Technology
ICT  Information and Communication Technology
MCA   Mobile Clinical Assistants 
NHS CFH  NHS Connecting for Health
PACS  Picture Archiving and Communications System
PAS  Patient Administration System
PDA  Personal Digital Assistant
PN  Parenteral Nutrition
PODs   Patients’ Own Drugs
TTO  To Take Out [discharge prescription]
WOW  Workstation on Wheels
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